Document:

<PAGE>

                                                                  Exhibit 10.186

                                 LOAN AGREEMENT

         LOAN AGREEMENT dated July 25, 2002 (the "Loan Agreement" or this
"Agreement") by and among PHARMACEUTICAL PRODUCT DEVELOPMENT, INC., a North
Carolina corporation (the "Borrower"), the subsidiaries and affiliates
identified on the signature pages hereto or hereafter joined as a Guarantor
hereunder (the "Guarantors", and together with the Borrower, the "Credit
Parties") and BANK OF AMERICA, N.A. (the "Bank").

                               W I T N E S S E T H

         WHEREAS, the Borrower has requested a $50 million revolving credit
facility for the purposes hereinafter set forth;

         WHEREAS, the Bank has agreed to make the requested credit facility
available to the Borrower on the terms and conditions hereinafter set forth;

         NOW, THEREFORE, IN CONSIDERATION of the premises and other good and
valuable consideration, the receipt and sufficiency of which is hereby
acknowledged, the parties hereto agree as follows:

         SECTION 1.  DEFINITIONS.

         "Bankruptcy Code" means the Bankruptcy Code in Title 11 of the United
States Code, as amended, modified, succeeded or replaced from time to time.

         "Business Day" means a day other than a Saturday, Sunday or other day
on which commercial banks in Charlotte, North Carolina are authorized or
required by law to close; provided, however, that when used in connection with a
rate determination, borrowing or payment in respect of a LIBOR Rate Loan, the
term "Business Day" shall also exclude any day on which banks in London, England
are not open for dealings in U.S. dollar deposits in the London interbank
market.

         "Closing Date" means the date hereof.

         "Commitment Period" means the period from and including the date hereof
to but excluding the earlier of (i) the Termination Date, or (ii) the date on
which the commitments hereunder shall have been terminated in accordance with
the provisions hereof.

         "Committed Amount" means the aggregate amount of the commitments of the
Bank hereunder, being initially $50,000,000.

         "Consolidated EBITDA" means, for any period for the Borrower and its
subsidiaries on a consolidated basis, the sum of (i) Consolidated Net Income,
plus (ii) to the extent deducted in determining net income, (A) Consolidated
Interest Expense, (B) taxes and (C) depreciation and amortization, in each case
on a consolidated basis determined in accordance with GAAP.

         "Consolidated EBITDAR" means, for any period for the Borrower and its
subsidiaries on a consolidated basis, the sum of Consolidated EBITDA plus rental
and lease expense, in each case on a consolidated basis determined in accordance
with GAAP.

         "Consolidated Fixed Charge Coverage Ratio" means, as of the last day of
each fiscal quarter, the ratio of Consolidated EBITDAR for the period of four
consecutive

<PAGE>

fiscal quarters ending as of such day to Consolidated Fixed Charges for the
period of four consecutive fiscal quarters ending as of such day.

         "Consolidated Fixed Charges" means, for the applicable period for the
Borrower and its subsidiaries on a consolidated basis, the sum of Consolidated
Interest Expense plus rental and lease expense, in each case as determined in
accordance with GAAP applied on a consistent basis. Except as expressly provided
otherwise, the applicable period shall be for the four consecutive fiscal
quarters ending as of the date of determination.

         "Consolidated Funded Debt" means Funded Debt of the Borrowers and its
subsidiaries on a consolidated basis determined in accordance with GAAP.

         "Consolidated Interest Expense" means, for any period for the Borrower
and its subsidiaries on a consolidated basis, all interest expense, including
the amortization of debt discount and premium, the interest component under
capital leases and the implied interest component under securitization
transactions, expense, in each case determined in accordance with GAAP applied
on a consistent basis. Except as expressly provided otherwise, the applicable
period shall be for the four consecutive fiscal quarters ending as of the date
of determination.

         "Consolidated Net Income" means, for any period for the Borrower and
its subsidiaries on a consolidated basis, net income as determined in accordance
with GAAP applied on a consistent basis, but excluding for purposes of
determining the Fixed Charge Coverage Ratio, (i) extraordinary gains or losses,
and any taxes on such excluded gains and any tax deductions or credits on
account of any such excluded losses, and (ii) one-time non-recurring charges
associated with mergers and acquisitions permitted hereunder. Except as
expressly provided otherwise, the applicable period shall be for the four
consecutive fiscal quarters ending as of the date of determination.

         "Consolidated Senior Funded Debt" means Consolidated Funded Debt that
is not Subordinated Debt.

         "Consolidated Senior Leverage Ratio" means, as of the last day of each
fiscal quarter, the ratio of Consolidated Senior Funded Debt on such day to
Consolidated EBITDA for the period of four consecutive fiscal quarters ending as
of such day.

          "Consolidated Total Leverage Ratio" means, as of the last day of each
fiscal quarter, the ratio of Consolidated Funded Debt on such day to
Consolidated EBITDA for the period of four consecutive fiscal quarters ending as
of such day.

         "Credit Documents" means, collectively, this Agreement and the Note.

         "Eurodollar Reserve Percentage" means for any day, the percentage
(expressed as a decimal and rounded upwards, if necessary, to the next higher
1/100th of 1%) which is in effect for such day as prescribed by the Federal
Reserve Board (or any successor) for determining the maximum reserve requirement
(including without limitation any basic, supplemental or emergency reserves) in
respect of Eurocurrency liabilities, as defined in Regulation D of such Board as
in effect from time to time, or any similar category of liabilities for a member
bank of the Federal Reserve System in New York City.

         "Extension of Credit" means the making of any loans (including the
extension of, or conversion into, Eurodollar Loans) or the issuance or extension
of any letter of credit hereunder.

         "Funded Debt" means, as of any day for the Borrower, without
duplication, (i) all indebtedness for borrowed money, (ii) all indebtedness and
obligations evidenced by bonds, debentures, notes or other similar instruments,
(iii) all obligations to pay the deferred purchase price of property or services
(other than

                                        2

<PAGE>

trade accounts payable arising in the ordinary course of business), (iv) all
obligations as lessee under capital leases, (v) all obligations of reimbursement
relating to letters of credit, bankers' acceptances or other similar instruments
(whether or not then drawn and owing), (vi) all Guaranty Obligations, (vii) the
attributed principal amount of any securitization transaction and (viii) all
obligations under any synthetic lease, tax retention operating lease,
off-balance sheet loan or other similar off-balance sheet financing product
where the product is considered borrowed money indebtedness for tax purposes,
but is classified as an operating lease for purposes of GAAP.

         "GAAP" means generally accepted accounting principles in the United
States applied on a consistent basis.

         "Governmental Authority" means any federal, state, local or foreign
court or governmental agency, authority, instrumentality or regulatory body.

         "Guaranteed Obligations" means:

               (a)   All unpaid principal of and interest on (including, without
         limitation, interest accruing at the then applicable rate provided in
         this Agreement after the maturity of the Loans and other obligations
         owing under this Agreement and interest accruing at the then applicable
         rate provided in this Agreement after the filing of any petition in
         bankruptcy, or the commencement of any insolvency, reorganization or
         like proceeding, relating to the Borrower, whether or not a claim for
         post-filing or post-petition interest is allowed in such proceeding)
         the Loans and all other obligations and liabilities of the Borrower to
         the Bank, whether direct or indirect, absolute or contingent, due or to
         become due, or now existing or hereafter incurred, which may arise
         under, out of, or in connection with, this Agreement, the Note or any
         other document relating hereto, in each case whether on account of
         principal, interest, reimbursement obligations, fees, indemnities,
         costs, expenses or otherwise (including, without limitation, all fees
         and disbursements of counsel to the Bank that are required to be paid
         by the Borrower pursuant to the terms of this Agreement); and

               (b)   all other indebtedness, liabilities and obligations of any
         kind or nature, now existing or hereafter arising, owing by the
         Borrower to the Bank, arising under any interest rate protection
         agreement, currency agreement or other agreement or arrangement,
         whether primary, secondary, direct, contingent, or joint and several.

         "Guaranty Obligation" means any obligation, contingent or otherwise,
directly or indirectly guaranteeing the indebtedness or other obligation of
another Person, including without limitation, (i) an agreement to purchase or
pay (or to supply or advance funds for the purchase or payment of) any such
indebtedness or other obligation (whether by way of partnership agreement,
keep-well agreement, comfort letter, maintenance agreement or the like), or (ii)
any arrangement entered into for the purpose of assuring payment of the
indebtedness or other obligation of another Person or otherwise protecting a
party from loss in respect thereof; provided that such term shall not include
endorsements for collection or deposit in the ordinary course of business.

         "Interest Payment Date" means (a) as to any Prime Loan, the last
Business Day of each March, June, September and December to occur while such
Loan is outstanding, (b) as to any LIBOR Rate Loan having an Interest Period of
three months or less, the last day of such Interest Period and (c) as to any
LIBOR Rate Loan having an Interest Period longer than three months, each day
which is three months after the first day of such Interest Period and the last
day of such Interest Period.

         "Interest Period" means with respect to any LIBOR Rate Loan,

                                        3

<PAGE>

               (i)        initially, the period commencing on the date of
         borrowing or conversion date, as the case may be, with respect to such
         LIBOR Rate Loan and ending one, two, three or six months thereafter, as
         selected by the Borrower in the notice of borrowing or notice of
         conversion given with respect thereto; and

               (ii)       thereafter, each period commencing on the last day of
         the immediately preceding Interest Period applicable to such LIBOR Rate
         Loan and ending one, two, three or six months thereafter, as selected
         by the Borrower by irrevocable notice to the Bank not less than three
         Business Days prior to the last day of the then current Interest Period
         with respect thereto;

               provided that the foregoing provisions are subject to the
    following:

                     (A)  if any Interest Period pertaining to a LIBOR Rate Loan
         would otherwise end on a day that is not a Business Day, such Interest
         Period shall be extended to the next succeeding Business Day unless the
         result of such extension would be to carry such Interest Period into
         another calendar month in which event such Interest Period shall end on
         the immediately preceding Business Day;

                     (B)  any Interest Period pertaining to a LIBOR Rate Loan
         that begins on the last Business Day of a calendar month (or on a day
         for which there is no numerically corresponding day in the calendar
         month at the end of such Interest Period) shall end on the last
         Business Day of the relevant calendar month;

                     (C)  if the Borrower shall fail to give notice as provided
         above, the Borrower shall be deemed to have selected a Prime Loan to
         replace the affected LIBOR Rate Loan as provided herein;

                     (D)  any Interest Period that would otherwise extend beyond
         the Termination Date shall end on the Termination Date; and

                     (E)  no more than 6 LIBOR Rate Loans may be in effect at
         any time. For purposes hereof, LIBOR Rate Loans with different Interest
         Periods shall be considered as separate LIBOR Rate Loans, even if they
         shall begin on the same date and have the same duration, although
         borrowings, extensions and conversions may, in accordance with the
         provisions hereof, be combined at the end of existing Interest Periods
         to constitute a new LIBOR Rate Loan with a single Interest Period.

         "LIBOR" means the arithmetic mean (rounded to the nearest 1/100th of
1%) of the offered rates for deposits in U.S. dollars for a period equal to the
Interest Period selected which appears on the Telerate Page 3750 at
approximately 11:00 A.M. London time, two (2) Business Days prior to the
commencement of the applicable Interest Period. If, for any reason, such rate is
not available, then "LIBOR" shall mean the rate per annum at which, as
determined by the Bank, U.S. dollars in the amount of $5,000,000 are being
offered to leading banks at approximately 11:00 A.M. London time, two (2)
Business Days prior to the commencement of the applicable Interest Period for
settlement in immediately available funds by leading banks in the London
interbank market for a period equal to the Interest Period selected.

         "LIBOR Rate" means a rate per annum (rounded upwards, if necessary, to
the next higher 1/100th of 1%) determined by the Bank pursuant to the following
formula:

               LIBOR Rate =                       LIBOR
                                   ------------------------------------
                                   1.00 - Eurodollar Reserve Percentage

                                        4

<PAGE>

         "LIBOR Rate Loan" means Loans hereunder bearing interest at a rate
determined by reference to the LIBOR Rate.

         "Lien" means any mortgage, pledge, hypothecation, assignment, security
interest, encumbrance, lien, preference or priority of any kind.

         "LOC Obligations" means, at any time, the sum of (i) the maximum amount
which is, or any time may become, available to be drawn under letters of credit
issued hereunder assuming compliance with all requirements for drawings referred
to therein, and (ii) the aggregate amount of unreimbursed drawings owing in
respect of letters of credit issued hereunder.

         "Loan" or "loan" shall mean revolving loans under Section 2.1 hereof.

         "Obligations" means, collectively, loans advanced and extended and
letters of credit issued hereunder.

         "Person" means any individual, partnership, joint venture, firm,
corporation, limited liability company, association, trust or other enterprise
(whether or not incorporated) or any Governmental Authority.

         "Prime Loan" means Loans hereunder bearing interest at a rate
determined by reference to the Prime Rate.

         "Prime Rate" means the rate of interest per annum publicly announced
from time to time by the Bank as its prime rate in effect at its principal
office in Charlotte, North Carolina, with each change in the Prime Rate being
effective on the date such change is publicly announced as effective (it being
understood and agreed that the Prime Rate is a reference rate used by the Bank
in determining interest rates on certain loans and is not intended to be the
lowest rate of interest charged on any extension of credit by the Bank to any
debtor).

         "Pro Forma Basis" means, with respect to any transaction, that such
transaction shall be deemed to have occurred as of the first day of the four
fiscal quarter period ending as of the most recent fiscal quarter end preceding
the date of such transaction with respect to which the Bank has received annual
or quarterly financial statements and accompanying officer's certificate.

         "Requirement of Law" means, as to any Person, the certificate of
incorporation and by-laws or other organizational or governing documents of such
Person, and any law, treaty, rule or regulation or determination of an
arbitrator or a court or other Governmental Authority, in each case applicable
or any of its material property is subject.

         "Subordinated Debt" means any indebtedness of the Borrower or any of
its subsidiaries which by its terms is expressly subordinated in right of
payment to the prior payment of the obligations of the Borrower and the
Guarantors under the Credit Documents on terms and conditions and evidenced by
documentation satisfactory to the Bank.

         "Termination Date" means June 30, 2003, or such later date as to which
the Bank may agree in its sole discretion.

         SECTION 2.  LOAN.

         2.1 Loan. During the Commitment Period, subject to the terms and
conditions hereof, the Bank agrees to make revolving loans to and to issue
letters of credit for the account of the Borrower upon request up to FIFTY
MILLION DOLLARS ($50,000,000) at any time outstanding in the aggregate

                                        5

<PAGE>

principal amount of Obligations. The loans hereunder may consist of Prime Loans
or LIBOR Rate Loans, or a combination thereof. The obligation of the Bank to
make any Extension of Credit is subject to the condition that the
Representations and Warranties set forth herein are true and correct in all
material respects. Letters of credit issued hereunder (i) shall be of a duration
reasonably acceptable to the Bank, but shall not, in any event, extend more than
ninety (90) days beyond the Termination Date, (ii) may be issued subject to any
additional terms and provisions provided in any application or other document
executed in connection therewith, and (iii) may be issued subject to The Uniform
Customs and Practice for Documentary Credits as published by the International
Chamber of Commerce.

         2.2   Notices. Requests by the Borrower for Extensions of Credit
hereunder (including extensions or conversions of loans hereunder), shall be
made by written notice (or telephone notice promptly confirmed in writing) by
12:00 Noon Charlotte, North Carolina time (i) on the Business Day of the
requested borrowing, extension or conversion in the case of Prime Loans, (ii) on
the third Business Day prior to the date of the requested borrowing, extension
or conversion in the case of Eurodollar Loans and (iii) on third Business Day
prior to the date of requested issuance or extension in the case of letters of
credit. Each request shall be in a minimum principal amount of $1,000,000 in the
case of LIBOR Rate Loans and $100,000 in the case of Prime Loans and, in each
case, integral multiples of $100,000 in excess thereof, and shall specify the
date of the requested borrowing, extension or conversion, the aggregate amount
to be borrowed, extended or converted and if an extension of conversion, the
loan which is being extended or converted, and whether the borrowing, extension
or conversion shall consist of LIBOR Rate Loans, Prime Loans or combination
thereof. If the Borrower shall fail to specify (A) the type of Loan requested
for a borrowing, the request shall be deemed a request for a LIBOR Rate Loan
with an Interest Period of one month, (B) the duration of the applicable
Interest Period in the case of LIBOR Rate Loans, the request shall be deemed to
be a request for an Interest Period of one month. Each request for an Extension
of Credit hereunder shall be deemed a reaffirmation that the Representations and
Warranties set forth herein are true and correct in all material respects as of
such date. Unless extended in accordance with the provisions hereof, LIBOR Rate
Loans shall be converted to Prime Loans at the end of the applicable Interest
Period.

         2.3   Interest Rate.

               (a)   Loans. Loans outstanding hereunder shall bear interest at a
per annum rate equal to (i) for any day that the average amount of outstanding
Obligations for such day exceeds an amount equal to fifty percent (50%) of the
Committed Amount, the LIBOR Rate plus seven-eighths of one percent (0.875%),
(ii) for any day that the average amount of outstanding Obligations for such day
is less than an amount equal to fifty percent (50%) of the Committed Amount, the
LIBOR Rate plus five-eighths of one percent (0.625%) or (iii) the Prime Rate, as
the Borrower may elect; provided that after the occurrence and during the
continuance of an Event of Default, the principal and, to the extent permitted
by law, interest on the Loan and any other amounts owing hereunder shall bear
interest, payable on demand, at a rate equal to the Prime Rate plus two percent
(2%). Interest will be payable in arrears on each Interest Payment Date.

               (b)   Letters of Credit. The unreimbursed portion of any drawing
under a letter of credit shall bear interest, payable on demand, at a per annum
rate equal to the Prime Rate plus two percent (2%) from the date of drawing.

         2.4   Repayment.

               (a)   Repayment of Loans. Unless sooner paid, the Loan shall be
due and payable in full on the Termination Date.

               (b)   Reimbursement of Letters of Credit. The Bank will notify
the Borrower of any drawing under a letter of credit issued hereunder and the
amount of any such drawing shall be due and

                                        6

<PAGE>

payable in full on the date of such drawing. Unless it shall receive direction
from the Borrower to the contrary, the Bank may, but shall not be required, to
make a loan advance to reimburse the amount of any such drawing. The Borrower's
reimbursement obligations hereunder shall be absolute and unconditional under
all circumstances irrespective of any rights of setoff, counterclaim or defense
to payment the Borrower may claim to have against the Bank, the beneficiary of
the letter of credit drawn upon or any other Person, including without
limitation any defense based on any failure of the Borrower or any other Credit
Party to receive consideration or the legality, validity, regularity or
unenforceability of the letter of credit.

         2.5   Note. The Loan shall be evidenced by a promissory note of the
Borrower dated as of the Closing Date, in the form of Annex A hereto (as
amended, modified, extended, renewed or replaced, the "Note").

         2.6   Fees.

               (a)   Facility Fee. In consideration of the commitments
hereunder, the Borrower agrees to pay to the Bank a facility fee (the "Facility
Fee") equal to fifteen basis points (0.15%) per annum on the average daily
unused portion of the Committed Amount for the applicable period. The Facility
Fee shall be payable quarterly in arrears on the 15th day following the last day
of each calendar quarter for the immediately preceding quarter (or portion
thereof) beginning with the first such date to occur after the date hereof.

               (b)   Letters of Credit Fees. In consideration of the commitments
relating to letters of credit hereunder, the Borrower agrees to pay the Bank a
fee (collectively the "Letter of Credit Fee") equal to five-eighths of one
percent (.625%) per annum on the average daily amount of LOC Obligations for the
applicable period plus other customary charges of administration of Letters of
Credit. The Letter of Credit Fee shall be payable at issuance in advance.

         2.7   Prepayments. The Loans may be prepaid in whole or in part without
premium or penalty. LIBOR Rate Loans may not be prepaid in whole or in part
prior to the end of the applicable Interest Period. Amounts prepaid may, subject
to the terms and conditions hereof, be reborrowed.

         2.8   Capital Adequacy. If the Bank shall have reasonably determined
that the adoption of or any change in any Requirement of Law regarding capital
adequacy or in the interpretation or application thereof as a consequence of its
obligations hereunder or compliance by the Bank or any corporation controlling
the Bank with any request or directive regarding capital adequacy (whether or
not having the force of law) from any central bank or Governmental Authority
made subsequent to the date hereof as a consequence of its obligations hereunder
does or shall have the effect of reducing the rate of return on the Bank's or
such corporation's capital as a consequence of its obligations hereunder to a
level below that which the Bank or such corporation could have achieved but for
such adoption, change or compliance (taking into consideration the Bank's or
such corporation's policies with respect to capital adequacy) by an amount
reasonably deemed by the Bank to be material, then from time to time, within 15
days after demand by the Bank, the Borrower shall pay to the Bank such
additional amount as shall be certified by the Bank as being required to
compensate it for such reduction. Such a certificate as to any additional
amounts payable under this subsection submitted by the Bank (which certificate
shall include a description in reasonable detail of the basis for the
computation) to the Borrower shall be conclusive absent manifest error.

         2.9   Inability to Determine Interest Rate. Notwithstanding any other
provision of this Agreement, if (i) the Bank shall reasonably determine (which
determination shall be conclusive and binding absent manifest error) that, by
reason of circumstances affecting the relevant market, reasonable and adequate
means do not exist for ascertaining LIBOR for such Interest Period, or (ii) the
Bank shall reasonably determine (which determination shall be conclusive and
binding absent manifest error) that

                                        7

<PAGE>

the LIBOR Rate does not adequately and fairly reflect the cost of funding LIBOR
Rate Loans, the Bank shall forthwith give telephone notice of such
determination, confirmed in writing, to the Borrower, and thereafter the right
to request and continue Loans as LIBOR Rate Loans shall be suspended until such
time as the conditions giving rise to such notice shall no longer exist. In the
event LIBOR Rate Loans are not available on account of operation of this
Section, the Bank will endeavor to provide an alternative index or reference
rate.

         2.10  Illegality. Notwithstanding any other provision of this
Agreement, if the adoption of or any change in any Requirement of Law or in the
interpretation or application thereof, in each case occurring after the Closing
Date, by the relevant Governmental Authority shall make it unlawful for the Bank
to make or maintain LIBOR Rate Loans as contemplated by this Agreement or to
obtain in the interbank eurodollar market through its LIBOR Lending Office the
funds with which to make such Loans, (a) the Bank shall promptly notify the
Borrower thereof, (b) the commitment of the Bank hereunder to make LIBOR Rate
Loans or continue LIBOR Rate Loans as such shall forthwith be suspended until
the Bank shall give notice that the condition or situation which gave rise to
the suspension shall no longer exist, and (c) Loans then outstanding as LIBOR
Rate Loans, if any, shall be converted on the last day of the Interest Period
for such Loans or within such earlier period as required by law to Prime Loans.
The Borrower hereby agrees promptly to pay the Bank, upon its demand, any
additional amounts necessary to compensate the Bank for actual and direct costs
(but not including anticipated profits) reasonably incurred in making any
repayment in accordance with this subsection including, but not limited to, any
interest or fees payable by the Bank to lenders of funds obtained by it in order
to make or maintain its LIBOR Rate Loans hereunder. A certificate as to any
additional amounts payable pursuant to this subsection submitted by the Bank, to
the Borrower shall be conclusive in the absence of manifest error.

         2.11  Requirements of Law. If the adoption of or any change in any
Requirement of Law or in the interpretation or application thereof or compliance
by the Bank with any request or directive (whether or not having the force of
law) from any central bank or other Governmental Authority, in each case made
subsequent to the date hereof:

               (i)   shall subject the Bank to any tax of any kind whatsoever
         with respect to any letter of credit or LIBOR Rate Loan made by it, or
         change the basis of taxation of payments to the Bank in respect thereof
         (except for changes in the rate of tax on the net income or franchise
         tax applicable to the Bank);

               (ii)  shall impose, modify or hold applicable any reserve,
         special deposit, compulsory loan or similar requirement against assets
         held by, deposits or other liabilities in or for the account of,
         advances, loans or other extensions of credit by, or any other
         acquisition of funds by, any office of the Bank which is not otherwise
         included in the determination of the LIBOR Rate hereunder; or

               (iii) shall impose on the Bank any other condition (excluding any
         tax of any kind whatsoever);

and the result of any of the foregoing is to increase the cost to the Bank of
making or maintaining LIBOR Loans or issuing letters of credit or to reduce any
amount receivable hereunder or under the Note, then, in any such case, the
Borrower shall promptly pay the Bank, within 15 days after its demand, any
additional amounts necessary to compensate the Bank for such additional cost or
reduced amount receivable as determined by the Bank with respect to its LIBOR
Rate Loans and/or letters of credit. A certificate as to any additional amounts
payable pursuant to this subsection submitted by the Bank, describing in
reasonable detail the nature of such event and a reasonably detailed explanation
of the calculation thereof, to the Borrower shall be conclusive in the absence
of manifest error.

                                        8

<PAGE>

         2.12  Indemnity. The Borrower hereby agree to indemnify the Bank and to
hold the Bank harmless from any funding loss or expense which the Bank may
sustain or incur (other than as a result of and to the extent the Bank's gross
negligence or willful misconduct) as a consequence of (a) default by the
Borrower in payment of the principal amount of or interest on any LIBOR Rate
Loan by the Bank in accordance with the terms hereof, (b) default by the
Borrower in accepting a LIBOR Rate Loan after the Borrower have given a notice
in accordance with the terms hereof, (c) default by the Borrower in making any
prepayment of a LIBOR Rate Loan after the Borrower have given a notice in
accordance with the terms hereof, and/or (d) the making by the Borrower of a
prepayment of a LIBOR Rate Loan, or the conversion thereof, on a day which is
not the last day of the Interest Period with respect thereto, in each case equal
to (i) the amount of interest which would have accrued on the amount so prepaid,
or not so paid, borrowed, converted or continued, for the period from the date
of such prepayment or of such failure to borrow, convert or continue to the last
day of such Interest Period (or, in the case of a failure to pay, borrow,
convert or continue, the Interest Period that would have commenced on the date
of such failure), in each case at the applicable rate of interest for such Loans
provided for herein (exclusive of any margin), over (ii) the amount of interest
(as reasonably determined by the Bank) which would have accrued to the Bank on
such amount by placing such amount on deposit for a comparable period with
leading banks in the interbank eurodollar market. A certificate as to any
additional amounts payable pursuant to this subsection submitted by the Bank, to
the Borrower shall be conclusive in the absence of manifest error.

         2.13  Taxes. All payments made by the Borrower hereunder or under any
Note will be made free and clear of, and without deduction or withholding for,
any present or future taxes, levies, imposts, duties, fees, assessments or other
charges of whatever nature now or hereafter imposed by any Governmental
Authority or by any political subdivision or taxing authority thereof or therein
with respect to such payments (but excluding (i) any tax imposed on or measured
by the net income or profits of a Lender pursuant to the laws of the
jurisdiction in which it is organized or the jurisdiction in which the principal
office or applicable lending office of the Bank is located or any subdivision
thereof or therein and (ii) any franchise taxes, branch taxes, taxes on doing
business or taxes on the overall capital or net worth of the Bank pursuant to
the laws of the jurisdiction in which it is organized or the jurisdiction in
which the principal office or its applicable lending office is located or any
subdivision thereof or therein) and all interest, penalties or similar
liabilities with respect thereto (all such non-excluded taxes, levies, imposts,
duties, fees, assessments or other charges being referred to collectively as
"Taxes"). If any Taxes are so levied or imposed, the Borrower agrees to pay the
full amount of such Taxes, and such additional amounts as may be necessary so
that every payment of all amounts due under this Agreement or under any Note,
after withholding or deduction for or on account of any such Taxes, will not be
less than the amount provided for herein or in such Note. The Borrower will
furnish to the Bank as soon as practicable after the date the payment of any
Taxes is due pursuant to applicable law certified copies (to the extent
reasonably available and required by law) of tax receipts evidencing such
payment by the Borrower. The Borrower agrees to indemnify and hold harmless, and
reimburse, the Bank upon its written request, for the amount of any Taxes so
levied or imposed and paid by the Bank. The agreements in this subsection shall
survive termination of this Agreement and payment of the Notes and all other
amounts payable hereunder.

         2.14  Payments and Computations. Payments shall be made hereunder in
U.S. dollars in immediately available funds, without offset, deduction,
counterclaim or withholding of any kind at the offices of the Bank provided in
the notice section hereof. Payments received after 2:00 P.M. (Charlotte, North
Carolina time) will be given credit the next following Business Day.
Computations of interest hereunder shall be made on the basis of actual number
of days elapsed over a year of 360 days.

         SECTION 3.  GUARANTY

         3.1   Guaranty. Each of the Guarantors hereby jointly and severally
guarantees to the Bank as hereinafter provided the prompt payment of the
Guaranteed Obligations in full when due (whether at

                                        9

<PAGE>

stated maturity, as a mandatory prepayment, by acceleration or otherwise and
after giving effect to any grace periods) strictly in accordance with the terms
hereof. Each of the Guarantors hereby further agrees that if any of the
Guaranteed Obligations are not paid in full when due (whether at stated
maturity, as a mandatory prepayment, by acceleration or otherwise and after
giving effect to any grace periods), the Guarantor will promptly pay the same,
without any demand or notice whatsoever, and that in the case of any extension
of time of payment or renewal of any of the Guaranteed Obligations, the same
will be promptly paid in full when due (whether at extended maturity, as a
mandatory prepayment, by acceleration or otherwise and after giving effect to
any grace periods) in accordance with the terms of such extension or renewal.
This is a guaranty of payment and not of collection.

         Notwithstanding any provision to the contrary contained herein or in
any other of the Credit Documents, to the extent the obligations of any
Guarantor as guarantor hereunder shall be adjudicated to be invalid or
unenforceable for any reason (including, without limitation, because of any
applicable state or federal law relating to fraudulent conveyances or transfers)
then the obligations of such Guarantor hereunder shall be limited to the maximum
amount that is permissible under applicable law (whether federal or state and
including, without limitation, the Bankruptcy Code).

         3.2   Obligations Unconditional. The obligations of the Guarantors
under Section 3.1 hereof are absolute and unconditional, irrespective of the
value, genuineness, validity, regularity or enforceability of this Agreement or
the Note, or any other agreement or instrument referred to herein or therein or
relating hereto or thereto, or any substitution, release or exchange of any
other guarantee of or security for any of the Guaranteed Obligations, and, to
the fullest extent permitted by applicable law, irrespective of any other
circumstance whatsoever which might otherwise constitute a legal or equitable
discharge or defense of a surety or guarantor, it being the intent of this
Section 3.2 that the obligations of the Guarantors hereunder shall be absolute
and unconditional under any and all circumstances. Each of the Guarantors agrees
that it shall have no right of subrogation, indemnity, reimbursement or
contribution against the Borrower or any other guarantor for amounts paid under
this Guaranty until such time as the Bank has been paid in full, all
commitments, if any, have been terminated and no Person or Governmental
Authority shall have any right to request any return or reimbursement of funds
from the Bank in connection with monies received under the Credit Documents.
Without limiting the generality of the foregoing, it is agreed that, to the
fullest extent permitted by law, the occurrence of any one or more of the
following shall not alter or impair the liability of the Guarantors hereunder
which shall remain absolute and unconditional as described above:

               (i)   at any time or from time to time, without notice to the
         Guarantors, the time for any performance of or compliance with any of
         the Guaranteed Obligations shall be extended, or such performance or
         compliance shall be waived;

               (ii)  any of the acts mentioned in any of the provisions of this
         Agreement or the Note or any other agreement or instrument referred to
         herein or therein or relating hereto or thereto shall be done or
         omitted;

               (iii) the maturity of any of the Guaranteed Obligations shall be
         accelerated, or any of the Guaranteed Obligations shall be modified,
         supplemented or amended in any respect, or any right under any of the
         Credit Documents or any other agreement or instrument referred to in
         the Credit Documents shall be waived or any other guarantee of any of
         the Guaranteed Obligations or any security therefor shall be released
         or exchanged in whole or in part or otherwise dealt with;

               (iv)  any Lien granted to, or in favor of, the Bank as security
         for any of the Guaranteed Obligations shall fail to attach or be
         perfected or shall be released or discharged in whole or in part; or

               (v)   any of the Guaranteed Obligations shall be determined to be
         void or voidable (including, without limitation, for the benefit of any
         creditor of any Guarantor or any other

                                       10

<PAGE>

     guarantor) or shall be subordinated to the claims of any Person (including,
     without limitation, any creditor of any guarantor).

With respect to its obligations hereunder, each of the Guarantors hereby
expressly waives diligence, presentment, demand of payment, protest and all
notices whatsoever, and any requirement that the Bank exhaust any right, power
or remedy or proceed against any Person under this Agreement or the Note or any
other agreement or instrument referred to herein or therein or relating hereto
or thereto, or against any other Person under any other guarantee of, or
security for, any of the Guaranteed Obligations.

     3.3 Reinstatement. The obligations of the Guarantors under this Section 3
shall be automatically reinstated if and to the extent that for any reason any
payment by or on behalf of any Person in respect of the Guaranteed Obligations
is rescinded or must be otherwise restored by any holder of any of the
Guaranteed Obligations, whether as a result of any proceedings in bankruptcy or
reorganization or otherwise, and each of the Guarantors agrees that it will
indemnify the Bank on demand for all reasonable costs and expenses (including,
without limitation, fees and expenses of counsel) incurred by the Bank in
connection with such rescission or restoration, including any such costs and
expenses incurred in defending against any claim alleging that such payment
constituted a preference, fraudulent transfer or similar payment under any
bankruptcy, insolvency or similar law.

     3.4 Certain Additional Waivers. Without limiting the generality of the
provisions of this Section 3, each of the Guarantors hereby specifically waives
the benefits of N.C. Gen. Stat. Sec. 26-7 through 26-9, inclusive. Each of the
Guarantors agrees that it shall have no right of recourse to security for the
Guaranteed Obligations, except through the exercise of the rights of subrogation
pursuant to Section 3.2.

     3.5 Remedies. Each of the Guarantors agrees that, to the fullest extent
permitted by law, as between the Guarantors, on the one hand, and the Bank, on
the other hand, the Guaranteed Obligations may be declared to be forthwith due
and payable as provided in Section 7.2 hereof (and shall be deemed to have
become automatically due and payable in the circumstances provided in said
Section 7.2) for purposes of Section 3.1 hereof notwithstanding any stay,
injunction or other prohibition preventing such declaration (or preventing the
Guaranteed Obligations from becoming automatically due and payable) as against
any other Person and that, in the event of such declaration (or the Guaranteed
Obligations being deemed to have become automatically due and payable), the
Guaranteed Obligations (whether or not due and payable by any other Person)
shall forthwith become due and payable by the Guarantors for purposes of said
Section 3.1.

     3.6 Continuing Guarantee. The guarantee in this Section 3 is a continuing
guarantee, and shall apply to all Guaranteed Obligations whenever arising.

     3.7 Rights of Contribution. The Guarantors hereby agree, as among
themselves, that if any Guarantor shall become an Excess Funding Guarantor (as
defined below), each other Guarantor shall, on demand of such Excess Funding
Guarantor (but subject to the succeeding provisions of this Section), pay to
such Excess Funding Guarantor an amount equal to such Guarantor's Pro Rata Share
(as defined below and determined, for this purpose, without reference to the
properties, assets, liabilities and debts of such Excess Funding Guarantor) of
such Excess Payment (as defined below). The payment obligation of any Guarantor
to any Excess Funding Guarantor under this Section shall be subordinate and
subject in right of payment to the prior payment in full of the obligations of
such Guarantor under the other provisions of this Section 3, and such Excess
Funding Guarantor shall not exercise any right or remedy with respect to such
excess until payment and satisfaction in full of all of such obligations. For
purposes hereof, (i) "Excess Funding Guarantor" shall mean, in respect of any
obligations arising under the other provisions of this Section 3 (hereafter, the
"Guarantied Obligations"), a Guarantor that has paid an amount in excess of its
Pro Rata Share of the Guarantied Obligations; (ii) "Excess Payment" shall mean,
in respect of any Guarantied Obligations, the amount paid by an Excess Funding
Guarantor in excess of its Pro Rata Share of such Guarantied Obligations; and
(iii) "Pro Rata Share", for the purposes of this Section, shall mean, for any
Guarantor, the ratio (expressed as a percentage) of (a) the amount by which the
aggregate present fair

                                       11

<PAGE>

saleable value of all of its assets and properties exceeds the amount of all
debts and liabilities of such Guarantor (including contingent, subordinated,
unmatured, and unliquidated liabilities, but excluding the obligations of such
Guarantor hereunder) to (b) the amount by which the aggregate present fair
saleable value of all assets and other properties of the Borrower and all of the
Guarantors exceeds the amount of all of the debts and liabilities (including
contingent, subordinated, unmatured, and unliquidated liabilities, but excluding
the obligations of the Borrower and the Guarantors hereunder) of the Borrower
and all of the Guarantors, all as of the Closing Date (if any Guarantor becomes
a party hereto subsequent to the Closing Date, then for the purposes of this
Section such subsequent Guarantor shall be deemed to have been a Guarantor as of
the Closing Date and the information pertaining to, and only pertaining to, such
Guarantor as of the date such Guarantor became a Guarantor shall be deemed true
as of the Closing Date).

     3.8 Joinder of Additional Guarantors. The Borrower may join additional
subsidiaries as Guarantors hereunder by way of execution of a Joinder Agreement,
a form of which is attached as Annex B.

     SECTION 4 CONDITIONS TO CLOSING

     4.1 Conditions. The effectiveness of this Agreement and extension of the
Loan hereunder are conditioned upon satisfaction of the following:

         (a) Receipt of multiple executed counterparts of this Agreement and the
Note, in form and substance satisfactory to the Bank.

         (b) Receipt of a legal opinion substantially in the form attached as
Annex C hereto.

         (c) Receipt of corporate documentation for the Credit Parties,
including resolutions, bylaws, articles of incorporation, certificates of good
standing and certificates of incumbency.

     SECTION 5 REPRESENTATIONS AND WARRANTIES

     5.1 Financial Condition. The consolidated balance sheet of the Borrower and
its consolidated subsidiaries dated as of March 31, 2002 together with related
consolidated statements of income and cash flows, are complete and correct in
all material respects and present fairly the financial condition and results
from operations of the entities and for the periods specified, subject in the
case of interim company-prepared statements to normal year-end adjustments.

     5.2 No Change. Since the date of the financial statements identified above,
there have been no developments or events which have had, or are likely to have,
a material adverse effect on the Borrower or on the condition (financial or
otherwise), operations, business or prospects of the Borrower and its
subsidiaries taken as a whole.

     5.3 Corporate Organization. Each of the Credit Parties is a corporation or
limited partnership duly organized, validly existing and in good standing under
the laws of the State of its incorporation, formation or organization, is
qualified to do business in each jurisdiction where failure to so qualify would
have a material adverse effect on the Borrower and its subsidiaries taken as a
whole and is in compliance with all Requirements of Law except to the extent
that failure to be in compliance would not have a material adverse effect on the
Borrower and its subsidiaries taken as a whole.

     5.4 Enforceable Obligation. Each of the Credit Parties has the power and
authority and legal right to enter into, deliver and perform under this
Agreement and has taken all necessary action to authorize the execution,
delivery and performance by them of this Agreement. This Agreement constitutes a
legal, valid and binding obligation of each of the Credit Parties enforceable
against them in accordance with its terms except as enforceability may be
limited by applicable bankruptcy, insolvency,

                                       12

<PAGE>

reorganization, moratorium or similar laws affecting the enforcement of
creditors' rights generally or by general equitable principles (whether
enforcement is sought by proceedings in equity or at law).

     5.5 Legal Proceedings. No claim, litigation or proceeding before any
arbitrator or Governmental Authority is pending, or to the knowledge of the
Credit Parties, threatened which if adversely determined would reasonably be
expected to have a material adverse effect on the Borrower and its subsidiaries
taken as a whole.

     5.6 No Default. No Event of Default or event or condition which with notice
or lapse of time, or both, would constitute an Event of Default, presently
exists.

     5.7 Federal Regulations. No part of the proceeds of the Loan hereunder will
be used, directly or indirectly, for any purpose in violation of Regulation U of
the Board of Governors of the Federal Reserve System, as amended, modified or
replaced.

     SECTION 6 COVENANTS

     The Borrower and the Guarantors covenant and agree to:

     6.1 Financial Statements. Furnish, or cause to be furnished, to the Bank:

         (a) Annual Audited Statements. As soon as available, but in any event
     within 90 days after the end of each fiscal year, audited consolidated and
     company-prepared consolidating balance sheets of the Borrower and its
     subsidiaries and related statements audited consolidated and
     company-prepared consolidating statements of income, retained earnings and
     cash flows, audited by Deloitte & Touche LLP, or other independent public
     accounting firm reasonably acceptable to the Bank, setting forth
     comparative information for the previous year, and reported without a
     "going concern" or like qualification or exception, or qualification
     indicating limitation of the scope of the audit; and

         (b) Quarterly Statements. As soon as available, and in any event within
     45 days after the end of each fiscal quarter, a company-prepared
     consolidated and consolidating balance sheet of the Borrower and its
     subsidiaries and related company-prepared consolidated and consolidating
     statements of income, retained earnings and cash flows for the quarter and
     for the portion of the year with comparative information for the
     corresponding periods for the previous year.

All such financial statements to be complete and correct in all material
respects (subject, in the case of interim statements, to normal recurring
year-end audit adjustments) and to be prepared in reasonable detail and in
accordance with GAAP throughout the periods reflected therein (except as
approved by such accountants and disclosed therein) and further accompanied by a
description of, and an estimation of the effect on the financial statements on
account of, a change in the application of accounting principles from a prior
period.

         (c) Other Information. Promptly upon request, such additional financial
     and other information as the Bank may reasonably request from time to time.

     6.2 Certificates and Notices. Furnish, or cause to be furnished, and give
notice to the Bank:

         (a) Officer's Certificate. Concurrently with the annual and quarterly
     financial statements referenced above, a certificate of a responsible
     officer of the Borrower stating that to the best of his knowledge and
     belief, (i) the financial statements fairly present in all material

                                       13

<PAGE>

     respects the financial condition of the parties to which such statements
     relate and (ii) the Borrower and the Guarantors are in compliance with the
     provisions of this Agreement in all material respects and no Event of
     Default, or event or condition which with notice or lapse of time, or both,
     would constitute an Event of Default exists hereunder (together with a
     financial covenant calculation worksheet demonstrating compliance therewith
     in reasonable detail).

         (b) Public and Other Information. Copies of reports and information
     which the Borrower or its subsidiaries sends to its stockholders or files
     with the Securities and Exchange Commission, and any other financial or
     other information as the Bank may reasonably request.

         (c) Notice of Default. Promptly, upon becoming aware thereof, notice of
     the occurrence of an Event of Default hereunder.

     6.3 Compliance with Laws. Comply will all Requirements of Law applicable to
them except to the extent that failure to comply therewith would not have a
material adverse effect on the Borrower and its subsidiaries taken as a whole.

     6.4 Books and Records. The Credit Parties will keep proper books and
records in conformity with GAAP and all Requirements of Law and permit the Bank
upon reasonable notice to visit and inspect such books and records.

     6.5 Financial Covenants.

         (a) Consolidated Total Leverage Ratio. As of the last day of each
     fiscal quarter, the Consolidated Total Leverage Ratio shall not be greater
     than 3.25:1.0.

         (b) Consolidated Senior Leverage Ratio. As of the last day of each
     fiscal quarter, the Consolidated Senior Leverage Ratio shall not be greater
     than 2.0:1.0.

         (c) Consolidated Fixed Charge Coverage Ratio. As of the last day of
     each fiscal quarter, the Consolidated Fixed Charge Coverage Ratio shall be
     not less than 3.0:1.0.

     6.6 [Reserved]

     6.7 Restriction on Liens. The Borrower will not, nor will it permit any of
its subsidiaries to, create, assume, incur or suffer to exist any Lien on any
property or asset of any kind, real or personal, tangible or intangible, now
owned or hereafter acquired by it or assign or subordinate any present or future
right to receive assets except:

         (a) Liens securing capital lease obligations and other purchase money
     Funded Debt;

         (b) Liens securing taxes, assessments or governmental charges or levies
     or the claims or demands of materialmen, mechanics, carriers, warehousemen,
     landlords and other like persons; provided that (A) with respect to Liens
     securing state and local taxes, such taxes are not yet payable, (b) with
     respect to Liens securing claims or demands of materialmen, mechanics,
     carriers, warehousemen, landlords and the like, such liens are unfiled and
     no other action has been taken to enforce the same, or (C) with respect to
     taxes, assessments or governmental charges or levies or claims or demand
     secured by such Liens, payment is not at the time required;

         (c) Liens not securing indebtedness which are incurred in the ordinary
     course of business in connection with workmen's compensation, unemployment
     insurance, unemployment insurance, social security and other like laws;

                                       14

<PAGE>

         (d) any Lien arising pursuant to any order of attachment, distraint or
     similar legal process arising in connection with court proceedings so long
     as the execution or other enforcement thereof is effectively stayed and the
     claims secured thereto are being contested in good faith by appropriate
     proceedings; and

         (e) zoning restrictions, easements, licenses, reservations, covenants,
     conditions, waivers, restrictions on the use of property or other minor
     encumbrances or irregularities of title which do not materially impair the
     use of any property in the operation or business of the Borrower or such
     subsidiary or the value of such property for the purpose of such business.

     6.8 Mergers and Acquisitions. The Borrower will not, nor will it permit any
of its subsidiaries to, enter into a transaction of merger or consolidation, nor
will it acquire all or substantially all of the capital stock (or other equity
interest) or assets of any other Person, except:

         (a) in the case of transactions of mergers and consolidation, (i) if a
     Credit Party is a party to the transaction, it shall be the surviving
     corporation, (ii) if the Borrower is a party to the transaction, it shall
     be the surviving corporation, and (iii) if the transaction is with a Person
     other than the Borrower or any of its subsidiaries, the Borrower shall
     demonstrate compliance with the financial covenants on a Pro Forma Basis;
     and

         (b) in all other cases, the Borrower shall demonstrate compliance with
     the financial covenants on a Pro Forma Basis.

     6.9 Investments. The Borrower will not, nor will it permit any of its
subsidiaries to, make loans or advances or otherwise make an investment in or
capital contribution to (collectively, an "Investment"), any other Person,
except:

         (a) cash and cash equivalents and other publicly traded equity and debt
     instruments reasonably acceptable to the Bank;

         (b) loans and advances to officers, directors, employees and
     shareholders not to exceed $2,000,000;

         (c) Investments in and to Digital Arts & Science in an aggregate
     principal amount (on a cost basis) not to exceed $1,500,000 at any time;

         (d) cash equity investments in and to ADoctorInYourHouse.com in an
     aggregate principal amount (on a cost basis) not to exceed $5,000,000 at
     any time;

         (e) loans and advances to NeoRx in an aggregate principal amount not to
     exceed $5,000,000 at any time;

         (f) capital stock of DNA Sciences, Inc. in an amount (on a cost basis)
     not to exceed $15,000,000;

         (g) Investments in and to a Credit Party; and

         (h) Investments of a nature not contemplated in the foregoing
     subsections in an amount not to exceed (a) $20,000,000 for any single
     Investment (or any series of related Investments) and (b) $50,000,000 in
     the aggregate in any fiscal year.

                                       15

<PAGE>

     For purposes of this Section 6.9, the term "Investment" shall not include
any merger, consolidation or acquisition of all or substantially all of the
capital stock (or other equity interest) or assets of any other Person which is
subject to Section 6.8 of the Loan Agreement.

     SECTION 7  EVENTS OF DEFAULT

     7.1 Event of Default. Each of the following shall constitute an "Event of
Default" hereunder: (i) the failure to make any payment of principal, interest,
fees or other amounts owing hereunder when due, (ii) any representation or
warranty made herein or in connection herewith shall prove to be false or
incorrect in any material respect, (iii) failure to observe or comply with any
covenants or provisions contained herein, (iv), the occurrence and continuance
of an event of default under any other note or agreement relating to
indebtedness for borrowed money owing by the Borrower or any Guarantor which
results in, or would permit, acceleration of such indebtedness, or would
otherwise cause such indebtedness to become due prior to its stated maturity,
(v) the filing of an action in bankruptcy or insolvency by the Borrower or any
Guarantor, (vi) the filing of an action in bankruptcy or insolvency against the
Borrower or any Guarantor and (vii) the Borrower or any Guarantor shall fail
within 30 days of the due date to pay bond or otherwise discharge any judgment,
settlement or order.

     7.2 Remedies. Upon the occurrence of an Event of Default, and at any time
thereafter, the Bank may by notice to the Borrower (i) terminate the commitments
hereunder and declare the unpaid principal of, and any accrued interest owing
on, the Loan and all other indebtedness or obligations owing hereunder or under
any of the other Credit Documents or in connection herewith or therewith,
immediately due and payable, whereupon the same shall be immediately due and
payable without presentment, demand, protest or other notice of any kind, all of
which are hereby waived by the Borrower, (ii) direct the Borrower to pay cash
collateral in the amount of 100% of the maximum amount available to be drawn
under letters of credit there outstanding, and (iii) enforce any other rights
and interests available under the Credit Documents or at law, including rights
of set off. Notwithstanding the foregoing, in the case of an Event of Default
described in clauses (v) or (vi) of Section 7.1 relating to bankruptcy and
insolvency, the commitments hereunder shall immediately terminate and the
Obligations and all accrued interest and all other indebtedness and other
amounts owing hereunder or under any of the other Credit Documents owing to the
Bank shall become immediately due and payable without presentment, demand,
protest or the giving of any notice or other action by the Bank, all of which
are hereby waived by the Borrower.

     SECTION 8  MISCELLANEOUS

     8.1 Notices. Notices and other communications shall be effective, and duly
given, (i) when received, (ii) when transmitted by telecopy or other facsimile
device to the numbers set out below if transmitted before 5:00 p.m. on a
Business Day, or otherwise on the next following Business Day, (iii) the day
following the day on which delivered prepaid to a reputable national overnight
air courier service, or (iv) the third Business Day following the day sent by
certified or registered mail postage prepaid, in each case to the parties at the
address shown below, or at such other address as may be specified by written
notice to the other parties:

         Borrower:         Pharmaceutical Product Development, Inc.
                           3151 17th Street Extension
                           Wilmington, North Carolina 28412
                           Attn:    Chief Financial Officer
                           Phone:   (910) 251-0081
                           Fax:     (910) 772-7056

         Bank:             BANK OF AMERICA, N.A.
                           380 Knollwood Street

                                       16

<PAGE>

                          Winston-Salem, North Carolina 27103
                          Attn:    Tom Johnson
                          Phone:   (336) 721-4058
                          Fax:     (336) 721-4099

     8.2 Right of Set-Off. In addition to other rights now or hereafter
available to the Bank under the Credit Documents or under applicable law, the
Bank may, after the occurrence of an Event of Default, exercise rights of
set-off and may appropriate and apply any and all deposits (general and
specific) or other amounts held or owing by the Bank to the Loan and other
amounts owing by the Borrower or any Guarantor hereunder or under the other
Credit Documents, regardless of whether the Loan or such other amounts are
contingent or unmatured, without presentment, demand, protest or notice of any
kind (any such rights of presentment, demand, protest or notice being hereby
waived).

     8.3 Benefit of Agreement. This Agreement shall be binding upon, and shall
inure to the benefit of, successors and assigns of the parties hereto; provided
that neither the Borrower nor any Guarantor may assign or transfer any its
obligations or interests without prior written consent of the Bank.

     8.4 No Waiver. No failure or delay on the part of the Bank in exercising
any right, power or privilege hereunder or under any other Credit Document and
no course of dealing between the Bank, on the one hand, and the Credit Parties,
on the other hand, shall operate as a waiver thereof; nor shall any single or
partial exercise of any right, power or privilege hereunder or under any other
Credit Document preclude any other or further exercise thereof or the exercise
of any other right, power or privilege hereunder or thereunder. The rights and
remedies provided herein are cumulative and not exclusive of any rights or
remedies which the Bank would otherwise have.

     8.5 Payment of Expenses. The Borrower agrees to: (i) pay all reasonable
out-of-pocket costs and expenses of the Bank in connection with (A) negotiation,
preparation, execution and delivery of the Credit Documents (including
reasonable fees and expenses of Bank counsel, Moore & Van Allen, PLLC) and any
amendments, waivers or consents relating to the Credit Documents and (B)
enforcement of the Credit Documents and the documents and instruments referred
to therein (including, without limitation, in connection with any such
enforcement, the reasonable fees and disbursements of counsel for the Bank);
(ii) pay and hold the Bank harmless from and against any and all present and
future stamp and other similar taxes with respect to the foregoing matters and
save the Bank harmless from and against any and all liabilities with respect to
or resulting from any delay or omission (other than to the extent attributable
to the Bank) to pay such taxes; and (iv) indemnify the Bank, its officers,
directors, employees and representatives from and hold each of them harmless
against any and all losses, liabilities, claims, damages or expenses incurred by
any of them as a result of, or arising out of, or in any way related to, or by
reason of any investigation, litigation or other proceeding (whether or not the
Bank is a party thereto) related to the entering into and/or performance of any
Credit Document or the use of proceeds of the Loan (including other extensions
of credit) hereunder or the consummation of any other transactions contemplated
in any Credit Document, including, without limitation, the reasonable fees and
disbursements of counsel incurred in connection with any such investigation,
litigation or other proceeding (but excluding any such losses, liabilities,
claims, damages or expenses to the extent incurred by reason of gross negligence
or willful misconduct on the part of the Person to be indemnified).

     8.6 Amendments. Neither this Agreement nor any of the other Credit
Documents may be amended or modified, nor shall consents or waivers be effective
except with the written consent of the parties hereto.

     8.7 Counterparts. This Agreement may be executed in any number of
counterparts, each of which when so executed and delivered shall be an original,
but all of which shall constitute one and the

                                       17

<PAGE>

same agreement. It shall not be necessary in making proof of this Agreement to
produce or account for more than one such counterpart.

     8.8   Headings. The headings of the sections and subsections hereof are
provided for convenience only and shall not in any way affect the meaning or
construction of any provision of this Agreement.

     8.9   Survival. The indemnities and payment obligations hereunder,
including those set out in Sections 2.8, 2.9, 2.10, 2.11, 2.12, 2.13 and 8.5,
and the representations and warranties made herein or in connection herewith
shall survive the making and repayment of the Loan and termination of
commitments hereunder.

     8.10  Governing Law. This Agreement and the rights and obligations of the
parties hereunder shall be governed by and construed in accordance with the laws
of the State of North Carolina.

     8.11. Arbitration; Consent to Jurisdiction and Service of Process.

     (a) UPON DEMAND OF ANY PARTY HERETO, WHETHER MADE BEFORE OR AFTER
INSTITUTION OF ANY JUDICIAL ACTION, ANY DISPUTE, CLAIM OR CONTROVERSY ARISING
OUT OF OR CONNECTED HEREWITH OR WITH THE CREDIT DOCUMENTS ("DISPUTES") SHALL BE
RESOLVED BY BINDING ARBITRATION AS PROVIDED HEREIN. DISPUTES MAY INCLUDE,
WITHOUT LIMITATION, TORT CLAIMS, COUNTERCLAIMS, CLAIMS BROUGHT AS CLASS ACTIONS
AND CLAIMS ARISING HEREFROM OR FROM CREDIT DOCUMENTS EXECUTED IN THE FUTURE.
ARBITRATION SHALL BE CONDUCTED UNDER THE COMMERCIAL FINANCIAL DISPUTES
ARBITRATION RULES (THE "ARBITRATION RULES") OF THE AMERICAN ARBITRATION
ASSOCIATION AND TITLE 9 OF THE U.S. CODE. ALL ARBITRATION HEARINGS SHALL BE
CONDUCTED IN CHARLOTTE, MECKLENBURG COUNTY, NORTH CAROLINA, OR SUCH OTHER PLACE
AS AGREED TO IN WRITING BY THE PARTIES. A JUDGMENT UPON THE AWARD MAY BE ENTERED
IN ANY COURT HAVING JURISDICTION, AND ALL DECISIONS SHALL BE IN WRITING. THE
PANEL FROM WHICH ALL ARBITRATORS ARE SELECTED SHALL BE COMPRISED OF LICENSED
ATTORNEYS HAVING AT LEAST TEN YEARS' EXPERIENCE REPRESENTING PARTIES IN SECURED
LENDING TRANSACTIONS. NOTWITHSTANDING THE FOREGOING, THIS ARBITRATION PROVISION
DOES NOT APPLY TO DISPUTES UNDER OR RELATED TO INTEREST PROTECTION AGREEMENTS.

     (b) Notwithstanding the preceding binding arbitration provision, the Bank
preserves certain remedies that may be exercised during a Dispute. The Bank
shall have the right to proceed in any court of proper jurisdiction or by self
help to exercise or prosecute the following remedies, as applicable: (i) all
rights to foreclose against any real or personal property or other security by
exercising a power of sale granted in the Credit Documents or under applicable
law, (ii) all rights of self help including peaceful occupation of real property
and collection of rents, set-off and peaceful possession of personal property,
(iii) obtaining provisional or ancillary remedies including injunctive relief,
sequestration, garnishment, attachment and appointment of receiver, (iv) when
applicable, a judgment by confession of judgment and (v) other remedies.
Preservation of these remedies does not limit the power of an arbitrator to
grant similar remedies that may be requested by a party in a Dispute.

     (c) BY EXECUTION AND DELIVERY OF THIS AGREEMENT, EACH OF THE PARTIES HERETO
ACCEPTS, FOR ITSELF AND IN CONNECTION WITH ITS PROPERTIES, GENERALLY AND
UNCONDITIONALLY, THE NON-EXCLUSIVE JURISDICTION RELATING TO ANY ARBITRATION
PROCEEDINGS CONDUCTED UNDER THE ARBITRATION RULES IN CHARLOTTE, MECKLENBURG
COUNTY, NORTH CAROLINA AND IRREVOCABLY AGREES TO BE BOUND BY ANY FINAL JUDGMENT
RENDERED THEREBY IN CONNECTION WITH

                                       18

<PAGE>

THIS AGREEMENT FROM WHICH NO APPEAL HAS BEEN TAKEN OR IS AVAILABLE. Each of the
parties hereto irrevocably agrees that all process in any such arbitration
proceedings or otherwise may be effected by mailing a copy thereof by registered
or certified mail (or any substantially similar form of mail), postage prepaid,
to it at its address set forth in Section 8.1 or at such other address of which
such party shall have been notified pursuant thereto, such service being hereby
acknowledged by each party hereto to be effective and binding service in every
respect. Each party hereto irrevocably waives any objection, including, without
limitation, any objection to the laying of venue or based on the grounds of
forum non conveniens which it may now or hereafter have to the bringing of any
such arbitration proceeding in any jurisdiction. Nothing herein shall affect the
right to serve process in any other manner permitted by law or shall limit the
right of any party to bring proceedings against the Borrower or any party hereto
in any court or pursuant to arbitration proceedings in any other jurisdiction.

                  [Remainder of Page Intentionally Left Blank]

                                       19

<PAGE>

         IN WITNESS WHEREOF, this Loan Agreement has been executed this day by
duly authorized officers of the undersigned parties.

BORROWER:                      PHARMACEUTICAL PRODUCT DEVELOPMENT, INC.,
                               a North Carolina corporation

                               By: /s/ Fred B. Davenport, Jr.
                                   ---------------------------------------------
                               Name:  Fred B. Davenport, Jr.
                               Title: President

GUARANTORS:                    PPD DEVELOPMENT, LP,
                               a Texas limited partnership

                                           By:  PPD GP, LLC,
                                           a Delaware limited liability company,
                                           its General Partner

                                           By: /s/ Fred B. Davenport, Jr.
                                               ---------------------------------
                                           Name:  Fred B. Davenport, Jr.
                                           Title: Vice President

BANK:                          BANK OF AMERICA, N.A.

                               By: /s/ Jane B. Sherrill
                                   ---------------------------------------------
                               Name: Jane B. Sherrill
                               Title: Assistant Vice President

<PAGE>

                                      Note

$50,000,000                                                        July 25, 2002

         PHARMACEUTICAL PRODUCT DEVELOPMENT, INC., a North Carolina corporation
(the "Borrower"), promises to pay to the order of BANK OF AMERICA, N.A., its
successor and assigns (the "Bank") on or before the Termination Date the
principal sum of FIFTY MILLION DOLLARS ($50,000,000) or, if less, the aggregate
unpaid principal amount of all Loans made by the Bank to the Borrower, in lawful
money of the United States in immediately available funds at the office of the
Bank as provided in the Loan Agreement referenced below or as otherwise directed
by the Bank pursuant to the terms of the Loan Agreement, together with interest,
in like money and funds, on the unpaid principal amount hereof at the rates and
on the dates as set forth in the Loan Agreement.

         This Note is issued pursuant to, and is entitled to the benefits of,
the Loan Agreement dated as of the date hereof (as the same may be amended or
modified and in effect from time to time, the "Loan Agreement") among the
Borrower, the Guarantors identified therein and the Bank, to which Loan
Agreement reference is hereby made for a statement of the terms and conditions
under which this Note may be prepaid or its maturity date accelerated.
Capitalized terms used herein and not otherwise defined herein are used with the
meanings attributed to them in the Loan Agreement.

         In the event payment of amounts due hereunder are accelerated under the
terms of the Loan Agreement, all such amounts shall become immediately due and
payable, without presentment, demand, protest or notice of any kind, all of
which are hereby waived. Further, in the event this Note is not paid when due at
any stated or accelerated maturity, the Borrower agrees to pay, in addition to
principal and interest, all costs of collection, including reasonable attorneys'
fees.

         This Note shall be governed by and construed in accordance with the
laws of the State of North Carolina.

                                    PHARMACEUTICAL PRODUCT DEVELOPMENT, INC.,
                                    a North Carolina corporation

                                    By: /s/ Fred B. Davenport, Jr.
                                        ----------------------------------------
                                    Name:  Fred B. Davenport, Jr.
                                    Title: President<PAGE>

                                                                  Exhibit 10.187

                    PHARMACEUTICAL PRODUCT DEVELOPMENT, INC.
--------------------------------------------------------------------------------
                    Deferred Compensation Plan for Directors

   __________________________________________________________________________

   __________________________________________________________________________

   __________________________________________________________________________

   __________________________________________________________________________

   __________________________________________________________________________

   __________________________________________________________________________

   __________________________________________________________________________

                                   Prepared By

                        Mercer Human Resource Consulting
                       462 South Fourth Avenue, Suite 1500
                              Louisville, KY 40202
                                  502/561-4500

                                  11 June 2002

<PAGE>

                    PHARMACEUTICAL PRODUCT DEVELOPMENT, INC.

                                TABLE OF CONTENTS
                                -----------------

<TABLE>
<CAPTION>
ARTICLE      SECTION                                                               PAGE
-------      -------                                                               ----
<S>                                                                                <C>
  I          Purpose and Effective Date ........................................     1
             --------------------------
              1.01        Title ................................................     1
              1.02        Purpose ..............................................     1
              1.03        Effective Date .......................................     1

  II         Definitions and Construction of the Plan Document .................     2
             -------------------------------------------------
              2.01        Beneficiary ..........................................     2
              2.02        Board ................................................     2
              2.03        Change in Control ....................................     2
              2.04        Code .................................................     3
              2.05        Committee ............................................     3
              2.06        Common Stock .........................................     3
              2.07        Company ..............................................     3
              2.08        Compensation .........................................     3
              2.09        Consideration Shares .................................     3
              2.10        Crediting Rate .......................................     3
              2.11        Date of Exercise .....................................     3
              2.12        Deferral .............................................     3
              2.13        Deferral Account .....................................     3
              2.14        Deferral Account Balance .............................     3
              2.15        Deferred Compensation ................................     4
              2.16        Director .............................................     4
              2.17        Disabled .............................................     4
              2.18        Election Date ........................................     4
              2.19        Election Form ........................................     4
              2.20        ERISA ................................................     4
              2.21        Exchange Act .........................................     4
              2.22        Fair Market Value ....................................     4
              2.23        Gain Shares ..........................................     4
              2.24        Gain Share Account ...................................     4
              2.25        Participant ..........................................     5
              2.26        Plan .................................................     5
              2.27        Plan Year ............................................     5
              2.28        Share Units ..........................................     5
              2.29        Stock Option .........................................     5
              2.30        Stock Option Gain Deferral Agreement .................     5
              2.31        Stock Option Plan ....................................     5
              2.32        Termination of Service ...............................     5
</TABLE>

                                        i

<PAGE>

<TABLE>
<S>                                                                                                  <C>
              2.33        Unforeseeable Financial Emergency ........................................  5
              2.34        Valuation Date ...........................................................  5
              2.35        Gender and Number ........................................................  5
              2.36        Titles ...................................................................  5

   III       Eligibility and Participation .........................................................  6
             -----------------------------
              3.01        Eligibility ..............................................................  6
              3.02        Participation ............................................................  6

    IV       Participant Deferrals of Compensation .................................................  7
             -------------------------------------
              4.01        Deferred Compensation ....................................................  7
              4.02        Duration of Election Form ................................................  7
              4.03        Election to Modify or Terminate Future Contributions .....................  7
              4.04        Vesting                                                                     7

     V       Stock Option Deferrals ................................................................  8
             ----------------------
              5.01        Deferral of Stock Option Gain ............................................  8
              5.02        Timing of Filing Stock Option Gain Deferral Agreement ....................  8
              5.03        Contents of Stock Option Gain Deferral Agreement .........................  8
              5.04        Manner of Exercising Option Shares .......................................  8
              5.05        Determination of Gain Shares .............................................  8
              5.06        Changes to the Stock Option Gain Deferral Agreement ......................  9
              5.07        Failure to Properly Exercise .............................................  9
              5.08        Vesting ..................................................................  9

    VI       Deferral Accounts, Gain Share Accounts and Credit Rating ..............................  10
             --------------------------------------------------------
              6.01        Deferral Account .........................................................  10
              6.02        Maintenance of Accounts ..................................................  10
              6.03        Interest .................................................................  10
              6.04        Valuation of Gain Share Accounts .........................................  10
              6.05        Common Stock Adjustments .................................................  10
              6.06        Section 16(b) ............................................................  11
              6.07        Statement Accounts .......................................................  11

   VII       Distribution ..........................................................................  12
             ------------
              7.01        Distribution of Deferral Account .........................................  12
              7.02        Form of Distribution .....................................................  12
              7.03        Timing of Distribution ...................................................  12
              7.04        Death or Disability Prior to Commencement of
                            Benefit Payments .......................................................  12
              7.05        Death of a Participant Subsequent to Commencement of
                            Benefit Payments .......................................................  12
              7.06        Redeferral Election ......................................................  12
              7.07        Taxes ....................................................................  12

</TABLE>

                                       ii

<PAGE>

<TABLE>
<S>                                                                                               <C>
  VIII       Withdrawals .....................................................................    13
             -----------
              8.01     Withdrawals for Unforeseeable Financial Emergency .....................    13
              8.02     Other Premature Withdrawals ...........................................    13
              8.03     Withdrawal Processing .................................................    13

    IX       Beneficiary .....................................................................    15
             -----------
              9.01     Beneficiary Designation ...............................................    15
              9.02     Proper Beneficiary ....................................................    15
              9.03     Minor or Incompetent Beneficiary ......................................    15
              9.04     No Beneficiary Designation ............................................    15

     X       Administration of the Plan ......................................................    16
             --------------------------
             10.01     Majority Vote .........................................................    16
             10.02     Finality of Determination .............................................    16
             10.03     Certificates and Reports ..............................................    16
             10.04     Indemnification and Exculpation .......................................    16
             10.05     Expenses ..............................................................    16

    XI       Claims Procedure ................................................................    17
             ----------------
             11.01     Written Claim .........................................................    17
             11.02     Denied Claim ..........................................................    17
             11.03     Review Procedure ......................................................    17
             11.04     Committee Review ......................................................    17

   XII       Nature of Company's Obligation ..................................................    18
             ------------------------------
             12.01     Company's Obligation ..................................................    18
             12.02     Creditor Status .......................................................    18

  XIII       Amendment and Termination of Plan ...............................................    19
             ---------------------------------
             13.01     Amendment .............................................................    19
             13.02     Change in Control .....................................................    19
             13.03     Termination ...........................................................    19

   XIV       Miscellaneous ...................................................................    20
             -------------
             14.01     Written Notice ........................................................    20
             14.02     Change of Address .....................................................    20
             14.03     Merger, Consolidation or Acquisition ..................................    20
             14.04     Employment ............................................................    20
             14.05     Non-transferability ...................................................    20
             14.06     Legal Fees ............................................................    20
             14.07     Tax Withholding .......................................................    20
             14.08     Acceleration of Payment ...............................................    20
             14.09     Applicable Law ........................................................    21
             14.10     Invalidity of Certain Provisions
</TABLE>

                                       iii

<PAGE>

                                    ARTICLE I

                           PURPOSE AND EFFECTIVE DATE

     1.01  Title. This Plan shall be known as Pharmaceutical Product
Development, Inc. Deferred Compensation Plan for Directors (hereinafter referred
to as the "Plan").

     1.02  Purpose. The purpose of the Plan is to permit members of the Board of
Directors of Pharmaceutical Product Development, Inc. to defer pre-tax
compensation. The Plan constitutes an unfunded "top hat" arrangement under Title
I of ERISA as well as for income tax purposes.

     1.03  Effective Date. The effective date of this Plan shall be June 15,
2002.

                                        1

<PAGE>

                                   ARTICLE II

                DEFINITIONS AND CONSTRUCTION OF THE PLAN DOCUMENT

     2.01  Beneficiary. "Beneficiary" shall mean the person or persons
designated, pursuant to Article IX, by the Participant to receive such payments
as may become payable hereunder after the death of said Participant.

     2.02  Board. "Board" shall mean the Board of Directors of the Company.

     2.03  Change in Control. "Change in Control" shall be deemed to have
occurred if:

           (a) Any "Person" as defined in Section 3(a)(9) of the Exchange Act,
including a "group" (as that term is used in Sections 13(d)(3) and 14(3)(2) of
the Exchange Act), but excluding the Company and any employee benefit plan
sponsored or maintained by the Company, including any trustee of such plan
acting as trustee, who:

               (i)  makes a tender or exchange offer for any shares of the
Common Stock pursuant to which any shares of the Common Stock are purchased (an
"Offer"); or

               (ii) together with its "affiliates" and "associates" (as those
terms are defined in Rule 12b-2 under the Exchange Act) becomes the "Beneficial
Owner" (within the meaning of Rule 13d-3 under the Exchange Act) of at least 20%
of the Common Stock (an "Acquisition");

           (b) The shareholders of the Company approve a definitive agreement or
plan to merge or consolidate the Company with or into another corporation, to
sell or otherwise dispose of all or substantially all of its assets, or to
liquidate the Company (individually, a "Transaction"); or

           (c) When, during any period of 24 consecutive months during the
existence of the Plan, the individuals who constitute the Board (the "Incumbent
Directors") at the beginning of such period cease for any reason other than
death to constitute at least a majority thereof; provided, however, that a
director who was not a director at the beginning of such 24-month period shall
be deemed to have satisfied such 24-month requirement, and be an Incumbent
Director, if such director was elected by, or on the recommendation of or with
the approval of, at least two-thirds of the directors who then qualify as
Incumbent Directors either actually, because they were directors at the
beginning of such 24-month period, or by prior operation of this Section
2.03(c).

           (d) An Offer, Acquisition or Transaction, as the case may be, is
approved by a majority of the Directors serving as members of the Board at the
time of the Offer, Acquisition or Transaction.

                                        2

<PAGE>

     2.04  Code. "Code" shall mean the Internal Revenue Code of 1986, as may be
amended from time to time.

     2.05  Committee. "Committee" shall mean the Committee established by the
Board of Directors designated to administer the Plan.

     2.06  Common Stock. "Common Stock" shall mean the Common Stock of
Pharmaceutical Product Development, Inc., $0.10 par value per share.

     2.07  Company. "Company" shall mean Pharmaceutical Product Development,
Inc. and any subsidiary or affiliated companies that adopt the Plan, with the
Company's approval, for their Directors.

     2.08  Compensation. "Compensation" shall mean the compensation paid to a
Director by the Company for services as rendered to the Company as a Director in
the form of either annual retainer or meeting fees.

     2.09  Consideration Shares. "Consideration Shares" shall mean shares of
Common Stock acquired by a Participant (a) on the open market or (b) through the
exercise of a nonqualified Stock Option that has been owned by the Participant
for at least (6) six months.

     2.10  Crediting Rate. "Crediting Rate" shall mean an interest rate equal to
the three month London Interbank Offered Rate (or similar index designated by
the Committee) plus 1.5%.

     2.11  Date of Exercise. "Date of Exercise" shall mean the date on or after
which Stock Options designated in a Stock Option Gain Deferral Agreement will be
exercised and any gain derived therefrom will be deferred pursuant to Article V
of this Plan; provided that such date shall be at least six months from the date
of the Stock Option Gain Deferral Agreement.

     2.12  Deferral. "Deferral" shall mean that portion of a Participant's
Compensation to be paid during a Plan year which a Participant elects to have
and is deferred during any one Plan Year. In the event of a Participant's
Termination of Service prior to the end of a Plan Year, such year's Deferral
shall be the actual amount deferred and withheld prior to such Termination of
Service.

     2.13  Deferral Account. "Deferral Account" shall mean the record of a
Participant's interest in this Plan represented by the Deferrals, with all
earnings thereon credited to such Account on behalf of the Participant under
this Plan, and all withdrawals and distributions thereon debited from such
Account.

     2.14  Deferral Account Balance. "Deferral Account Balance" shall mean with
respect to a Participant the sum of (i) his or her Deferred Compensation, plus
(ii) interest credited in accordance with Article V of this Plan, less (iii) all
withdrawals and distributions. This account shall be a bookkeeping entry only
and shall be utilized solely as a device for the measurement and determination
of the amounts to be paid to a Participant pursuant to this Plan.

                                        3

<PAGE>

     2.15  Deferred Compensation. "Deferred Compensation" shall mean the sum of
all of a Participant's Deferrals.

     2.16  Director. "Director" shall mean a non-employee member of the Board.

     2.17  Disabled. "Disabled" shall mean the total and permanent disability of
a Participant, as determined under the terms of the long-term disability plan of
the Company, or, in the absence of a long-term disability plan, as determined by
the Board, in its sole and absolute discretion.

     2.18  Election Date. "Election Date" shall mean the date established by the
Committee as the date before which a Director must submit a valid Election Form
to the Committee to effect a Deferral hereunder. The applicable Election Dates
can be no later than the following: (a) 30 days after the Effective Date of the
Plan for Directors who are eligible to participate at the time the Plan is
adopted, (b) 30 days after a newly eligible Director is notified of the right to
participate in the Plan, or (c) December 15 prior to any following Plan Year if
(a) or (b) above do not apply.

     2.19  Election Form. "Election Form" shall mean the form established from
time to time by the Committee that a Director completes, signs and returns to
the Committee to make a Deferral under the Plan.

     2.20  ERISA. "ERISA" shall mean the Employee Retirement Income Security Act
of 1974, as amended from time to time.

     2.21  Exchange Act. "Exchange Act" shall mean the Securities Exchange Act
of 1934, as amended, and all rules and regulations promulgated thereunder.

     2.22  Fair Market Value. "Fair Market Value," with respect to a share of
Common Stock as of any date, shall mean (a) the closing sales price of the
Common Stock on the NASDAQ National Market System or on any such other exchange
on which the Common Stock is traded on such date, or in the absence of reported
sales on such date, the closing sales price on the immediately preceding date on
which sales were reported, or (b) in the event there is no public market for the
Common Stock on such date, the Fair Market Value as determined in good faith by
the Committee in its sole and absolute discretion.

     2.23  Gain Shares. "Gain Shares" shall mean the shares of Common Stock
determined in accordance with the provisions of Section 5.05 hereof resulting
from the exercise of any Stock Option pursuant to Article V of this Plan.

     2.24  Gain Share Account. "Gain Share Account" shall mean the record of a
Participant's interest in this Plan represented by the number of the Share Units
related to Gain Shares, adjusted for hypothetical gains, earnings dividends,
losses, distributions, withdrawals and other similar activities.

                                        4

<PAGE>

     2.25  Participant. "Participant" shall mean a Director who has Deferred
Compensation pursuant to the terms of this Plan, and whose Deferral Account
Balance and/or Gain Share Account Balance has not yet been fully distributed.

     2.26  Plan. "Plan" shall mean the Pharmaceutical Product Development, Inc.
Deferred Compensation Plan for Directors as described in this instrument and as
amended from time to time.

     2.27  Plan Year. "Plan Year" shall mean a calendar year.

     2.28  Share Units. "Share Units" shall mean units of deemed investment in
shares of Common Stock in accordance with Article V of the Plan.

     2.29  Stock Option. "Stock Option" shall mean an option to purchase Common
Stock from the Company that was granted under a Stock Option Plan.

     2.30  Stock Option Gain Deferral Agreement. "Stock Option Gain Deferral
Agreement" shall mean the form established from time to time by the Committee
that a Director completes, executes and returns to the Committee to defer
receipt of Gain Shares received from the exercise of a Stock Option pursuant to
Article V hereof.

     2.31  Stock Option Plan. "Stock Option Plan" shall mean collectively the
equity incentive plans adopted by the Company from time to time or under which
the Company has Stock Options outstanding, and individually, such equity
incentive plan governing any particular Stock Option.

     2.32  Termination of Service. "Termination of Service" or similar
expression shall mean the termination of the Participant's service as a Director
of the Company and of any division, subsidiary or affiliate thereof for any
reason. A Disabled Participant shall be deemed to have terminated service for
purposes of this Plan.

     2.33  Unforeseeable Financial Emergency. "Unforeseeable Financial
Emergency" shall mean an unanticipated emergency that is caused by an event
beyond the control of the Participant that would result in severe financial
hardship to the Participant resulting from (i) a sudden and unexpected illness
or accident of the Participant or a dependent of the Participant, (ii) a loss of
the Participant's property due to casualty, or (iii) such other extraordinary
and unforeseeable circumstances arising as a result of events beyond the control
of the Participant, all as determined in the sole discretion of the Committee.

     2.34  Valuation Date. "Valuation Date" shall mean, for purposes of Deferral
Accounts, the last day of each calendar quarter; and for purposes of the
valuation of, or distribution or withdrawal from a Gain Share Account, the date
of such valuation, distribution, or withdrawal.

     2.35  Gender and Number. Wherever the context so requires, masculine
pronouns include the feminine and singular words shall include the plural.

     2.36  Titles. Titles of the Articles of this Plan are included for ease of
reference only and are not to be used for the purpose of construing any portion
or provision of this Plan document.

                                        5

<PAGE>

                                   ARTICLE III

                          ELIGIBILITY AND PARTICIPATION

     3.01   Eligibility. All Directors are eligible to participate in the Plan.

     3.02   Participation. A Director may elect to participate in the Plan by
completing, signing and returning to the Committee a duly executed Election Form
no later than the applicable Election Date or a Stock Option Gain Deferral
Agreement. A Deferral Account and/or a Gain Share Account, as the case may be,
will be established for each Director at the time an Election Form and/or Stock
Option Gain Deferral Agreement is received by the Committee.

                                        6

<PAGE>

                                   ARTICLE IV

                      PARTICIPANT DEFERRALS OF COMPENSATION

     4.01   Deferred Compensation. A Director may elect to defer up to 100% of
his or her annual Compensation until the earlier to occur of such Director's
Termination of Service, death or Disability. A Director who desires to make a
Deferral shall file an election Form pursuant to procedures specified by the
Committee (a) specifying the applicable Deferral; (b) authorizing such
Director's Compensation payable for a Plan Year to be so reduced and deferred
hereunder; and (c) indicating the form of payment of amounts deferred hereunder.
The amounts deferred, which are the Participant's Deferred Compensation, shall
be added to the Participant's Deferral Account.

     4.02   Duration of Election Form. If properly received by the Committee on
or before the applicable Election Date, a Deferral hereunder will be effective
only with respect to Compensation paid in the Plan Year to which the Deferral
applies. A Participant's Deferral may be modified or terminated as provided in
Section 4.03. Future deferrals will be terminated automatically for any
Participant who is deemed (by the Committee) to no longer be eligible for
participation in the Plan.

     4.03   Election to Modify or Terminate Future Contributions. Subject to the
provisions of Sections 8.01 and 8.02 hereof, all Deferrals hereunder are
irrevocable. A Participant who desires to modify or terminate the amount of
future Compensation being deferred under the Plan or to change the form of
payment of Deferrals must notify the Committee in writing on an Election Form
provided by the Committee. Elections to decrease or terminate deferrals of
future Compensation shall become effective as soon as administratively possible.
Elections to increase deferrals of future Compensation shall become effective on
January 1 of the next Plan Year. Elections to change the form of payment of
Deferrals hereunder must be made at least twelve (12) months prior to the
payment or commencement of payment of such Deferrals.

     4.04   Vesting. A Participant shall be fully vested at all times in his or
her Deferral Account Balance.

                                        7

<PAGE>

                                    ARTICLE V

                           STOCK OPTION GAIN DEFERRALS

     5.01   Deferral of Stock Option Gain. Subject to provisions of this Article
V, Directors may elect to defer the receipt and distribution of the gain related
to the exercise of Stock Options until the earlier to occur of Termination of
Service, death or Disability, by filing a Stock Option Gain Deferral Agreement
with the Committee. A Stock Option Gain Deferral Agreement may be filed at any
time with respect to any number of Stock Options.

     5.02   Timing of Filing Stock Option Gain Deferral Agreement. A Stock
Option Gain Deferral Agreement must be filed at least six months prior to the
Date of Exercise and no later than the day immediately preceding the first day
of the six-month period ending on the expiration date of the Stock Option. A
Stock Option with respect to which a Stock Option Gain Deferral Agreement has
been filed may not be exercised prior to the date specified in the Stock Option
Gain Deferral Agreement. A Participant must be a Director on the Date of
Exercise to effect a Deferral of Gain Shares hereunder.

     5.03   Contents of Stock Option Gain Deferral Agreement. Each Stock Option
Gain Deferral Agreement shall set forth: (a) the number of Stock Options to be
exercised; (b) the date of grant of the Stock Options; (c) the Date of Exercise;
(d) the form of payment of the Gain Shares; and (e) any other item determined to
be appropriate by the Committee. Gain Shares shall be distributed in the form of
Common Stock.

     5.04   Manner of Exercising Option Shares. A Participant who desires to
exercise a Stock Option and to defer current receipt and distribution of the
related Gain Shares must follow the procedures and requirements that are
applicable to the Stock Option under the Stock Option Plan, including the
procedures and requirements relating to the exercise of an Option; provided,
however, that in the case of a deferral of Gain Shares under this Plan, the
Participant shall only be permitted to tender Consideration Shares to pay the
entire exercise price for any such Stock Option exercised. Notwithstanding the
foregoing, the Committee may in its discretion accept documentation that the
Participant owns the number of Consideration Shares necessary to pay the
exercise price for the Stock Options.

     5.05   Determination of Gain Shares. Upon exercise of a Stock Option, the
Gain Shares resulting from the exercise of the Stock Option which the
Participant has elected to defer hereunder shall be determined as follows: (a)
the aggregate exercise price for all Stock Options to be exercised shall be
determined by multiplying the exercise price of the Stock Option by the number
of Stock Options to be exercised at that price; (b) the number of Consideration
Shares needed to pay the exercise price for such Stock Options shall be
determined by dividing the aggregate exercise price from (a) above by the Fair
Market Value of one share of Common Stock on the Date of Exercise; and (c) the
difference between the aggregate Fair Market Value on the Date of Exercise of
the shares of Common Stock acquired upon the exercise of the Stock Options and
the aggregate exercise price of such Stock Options, divided by the Fair Market
Value of one

                                        8

<PAGE>

share of Common Stock on the Date of Exercise, shall be the number of Gain
Shares resulting from such exercise.

     5.06   Changes to the Stock Option Gain Deferral Agreement. Subject to the
provisions of Article VIII, all deferrals of Gain Shares hereunder are
irrevocable. A Participant may not increase the amount of his Gain Share
deferrals occurring under any given Stock Option Gain Deferral Agreement
following submission of the Stock Option Gain Deferral Agreement. A Participant
may decrease or terminate a Gain Share deferral any time prior to the Date of
Exercise by filing, on such forms and subject to such limitations and
restrictions as the Committee may prescribe in its discretion, a revised Stock
Option Gain Deferral Agreement with the Committee. Under no circumstances may a
Participant's Stock Option Gain Deferral Agreement be made, modified or revoked
retroactively. Elections to change the form of payment of Gain Shares hereunder
must be made at least twelve (12) months prior to the payment or commencement of
payment of such Gain Shares.

     5.07   Failure to Properly Exercise. If a Participant makes a valid
election under this Article V to defer Gain Shares and if the Stock Option
expires without a proper exercise of the Stock Option by the Participant, or if
the Participant fails to properly tender or attest to the Consideration Shares
by the last day of the Stock Option term, the Participant shall forfeit any
opportunity to exercise the Stock Option and the Stock Option shall be canceled
as of the end of the last business day of the Stock Option term, according to
the terms of the Stock Option Plan.

     5.08   Vesting. A Participant shall be fully vested at all times in his or
her Gain Share Account.

                                        9

<PAGE>

                                   ARTICLE VI

            DEFERRAL ACCOUNTS, GAIN SHARE ACCOUNTS AND CREDITING RATE

     6.01   Deferral Account. A Participant's Deferrals hereunder will be
credited to the Participant's Deferral Account as of the date on which the
Participant's Compensation would otherwise have been paid to the Participant had
it not been deferred. All amounts credited to a Participant's Deferral Account
shall be treated as a reduction of Compensation otherwise payable to such
Participant. Gain Shares deferred hereunder shall be credited by the Committee
to the Participant's Gain Share Account as of the Date of Exercise.
Distributions and withdrawals pursuant to Articles VII and VIII shall be debited
against a Participant's Deferral Account and Gain Share Account, as the case may
be.

     6.02   Maintenance of Accounts. Separate Deferral Accounts and Gain Share
Accounts shall be maintained for each Participant, and more than one Deferral
Account and Gain Share Account may be maintained for a Participant, as deemed
necessary by the Committee for administrative purposes. A Participant's Deferral
Account(s) and Gain Share Account(s) shall be utilized solely as a device for
the measurement and determination of the amounts to be paid to the Participant
pursuant to this Plan, and shall not constitute or be treated as a trust fund of
any kind. The Committee shall determine the balance of each Deferral Account and
each Gain Share Account as of each Valuation Date, by adjusting the balance of
such Deferral Account and Gain Share Account as of each Valuation Date to
reflect changes in the value of the Common Stock (in the case of Gain Share
Accounts), interest credits pursuant to this Article VI (in the case of Deferral
Accounts), and distributions and withdrawals pursuant to Articles VII and VIII
hereof.

     6.03   Interest. Prior to any distribution of a Participant's Deferral
Account Balance under Article VI herein, the Company shall credit the Deferral
Account with interest on each Valuation Date at the Crediting Rate. Interest
credits to the Deferral Account Balance in accordance with this Article VI shall
continue until the Deferral Account Balance is paid in full to the Participant
or the Participant's Beneficiary.

     6.04   Valuation of Gain Share Accounts. Gain Share Accounts are
bookkeeping accounts, the value of which shall be based upon the performance of
the Common Stock. Any and all dividends paid with respect to the Common Stock
will be deemed to be immediately reinvested in Common Stock. It is understood
and agreed that the Company assumes no risk of any decrease in the value of the
Common Stock, and the Company's sole obligations are to maintain the
Participant's Gain Share Account and make payments to the Participant as herein
provided.

     6.05   Common Stock Adjustments. In the event of a stock dividend, split-up
or combination of the Common Stock, merger, consolidation, reorganization or
recapitalization affecting the Common Stock, such that an adjustment is
determined by the Committee to be appropriate in order to prevent dilution or
enlargement of the benefits or potential benefits intended to be made available
under this Plan, then the Committee may make appropriate

                                       10

<PAGE>

adjustments to the number of Share Units credited to any Gain Share Account. The
determination of the Committee as to such adjustments, if any, shall be binding
and conclusive.

     6.06   Section16(b). Notwithstanding any other provision of this Plan, the
Committee shall adopt such procedures as it may determine are necessary to
ensure that with respect to any Participant who is actually or potentially
subject to Section 16(b) of the Exchange Act, the crediting of deemed shares to
such Participant's Gain Share Account is not deemed to be a nonexempt purchase
for purposes of such Section 16(b), including without limitation requiring that
no shares of Common Stock relating to such deemed shares may be distributed for
six months after being credited to such Gain Share Account.

     6.07   Statement Accounts. The Committee shall provide periodically to each
Participant a statement setting for the balance of such Participant's Deferral
Account(s) and Gain Share Account(s) as of the end of the most recently
completed accounting period, in such form as the Committee deems desirable.

                                       11

<PAGE>

                                   ARTICLE VII

                                  DISTRIBUTION

     7.01   Distribution of Deferral Account. Distribution of the value of a
Participant's Deferral Account Balance and Gain Share Account Balance shall be
in a lump sum or in semi-annual installments over a period of five (5) years, as
specified on the Participant's Election Form and/or Stock Option Gain Deferral
Agreement. If a payment form is not specified on an Election Form for any
particular Plan Year in which the Participant made a Deferral, a Participant's
Deferral Account Balance and/or Gain Share Account balance for that Plan Year
shall be distributed as a lump sum upon the Participant's Termination of
Service. If the Participant has elected to receive payments from a Deferral
Account or Gain Share Account in installments, the Company shall make
semi-annual payments in cash from such Deferral Account or in Common Stock from
such Gain Share Account, each of which shall consist of an amount equal to (i)
the balance of such Deferral Account or Gain Share Account as of the Valuation
Date preceding the payment date, times (ii) a fraction, the numerator of which
is one and the denominator of which is the number of remaining installments
(including the installment being made). The first such installment shall be paid
on the first to occur of January 1 or July 1 immediately following the
Participant's Termination of Service and each subsequent installment shall be
paid on or about each January 1 and July 1 thereafter for the five (5) year
period.

     7.02   Form of Distribution. All distributions of a Participant's Deferral
Account shall be made in cash only. All distributions of a Participant's Gain
Share Account shall be in the form of shares of Common Stock, based upon the
Fair Market Value of the Common Stock on the date of distribution.

     7.03   Timing of Distribution. Distributions shall commence, or be paid in
a lump sum if so elected, on the first January 1 or July 1 immediately following
the earliest to occur of a Participant's Termination of Service, death or
Disability.

     7.04   Death or Disability Prior to Commencement of Benefit Payments. In
the event of a Participant's death or Disability prior to the commencement of
benefit payments hereunder, an amount equal to the Participant's Deferral
Account Balance and/or Gain Share Account balance shall be paid to the
Participant's Beneficiary in a lump sum or in semi-annual installments over a
period of five (5) years, as specified on the Participant's Election Form and/or
Stock Option Gain Deferral Agreement, on the first January 1 or July 1
immediately following the Participant's death or Disability.

     7.05   Death of a Participant Subsequent to Commencement of Benefit
Payments. In the event of the death of a Participant subsequent to commencement
of benefit installment payments hereunder but prior to completion of such
payments, the installments shall continue and shall be paid to the designated
Beneficiary as if the Participant had survived.

     7.06   Redeferral Election. Notwithstanding the foregoing, a Participant
will be permitted to elect to change the form of payments for previous
Deferrals, provided that the redeferral election must be made at least one full
calendar year prior to the date on which such distribution would be made or
commence to be made in the absence of such redeferral. A

                                       12

<PAGE>

redeferral election may be made by submitting an amended Deferral Election Form
or Stock Option Gain Deferral Agreement, as the case may be, or in such other
manner as is provided by the Committee.

     7.07   Taxes. Each Participant shall be responsible for the payment of any
and all income and employment taxes which are due and payable on amounts
distributed hereunder.

                                       13

<PAGE>

                                  ARTICLE VIII

                                   WITHDRAWALS

     8.01   Withdrawals for Unforeseeable Financial Emergency. At the request of
a Participant in the event of an Unforeseeable Financial Emergency or at the
request of any of the Participant's Beneficiaries after the Participant's death,
the Committee may, in its sole discretion, accelerate and pay all or part of the
value of a Participant's Deferral Account balance or Gain Share Account balance.
An accelerated distribution hereunder for an Unforeseeable Financial Emergency
must be limited to only that amount necessary to relieve the Unforeseeable
Financial Emergency (plus any appropriate taxes). Amounts to be distributed to a
Participant hereunder will be subject to applicable tax withholding.

     8.02   Other Premature Withdrawals. A Participant may request the
withdrawal of all or part of such Participant's Deferral Account or Gain Share
Account (not in excess of the balance of such Deferral Account or Gain Share
Account) prior to date of distribution under this Plan, for reasons other than a
financial need. The Participant will acknowledge and agree that in consideration
for the current payment of the relevant portion of the Participant's Deferral
Account or Gain Share Account, the Participant will forfeit ten percent (10%) of
the total pre-withdrawal value of such portion of the Participant's Deferral
Account or Gain Share Account. In addition, the Participant will be precluded
from further participation in the Plan for a period of twelve (12) months
following the month during which the Participant's withdrawal request is
received by the Committee.

     8.03   Withdrawal Processing.

            (a) Minimum Amount. There is no minimum payment for any type of
withdrawal.

            (b) Application by Participant. To apply for any type of withdrawal,
a Participant must submit to the Committee a withdrawal request, in accordance
with such uniform and nondiscriminatory procedure as will be established by the
Committee.

            (c) Approval by Committee. The Committee is responsible for
determining that a withdrawal request conforms to the requirements described in
this Article and notifying the Company of any payments to be made in a timely
manner. With respect to any withdrawal request under Section 8.01 hereof, the
Committee's decision to allow a Participant to withdraw all or part of such
Participant's Deferral Account or Gain Share Account in connection with an
Unforeseeable Financial Emergency will be based on the facts and circumstances
of each case. However, in no event will the amount withdrawn exceed the lesser
of the amount which the Committee deems necessary to satisfy such financial need
(plus any appropriate taxes) or the balance of such Participant's Deferral
Account or Gain Share Account. Any request to make a withdrawal by a member of
the Committee may be approved only by disinterested members of the Committee, or
if none, by the Board.

                                       14

<PAGE>

            (d) Time of Processing. The Company will make payment to the
Participant as soon as is administratively feasible following approval of the
withdrawal request.

            (e) Medium and Form of Payment. The medium of payment for
withdrawals from Deferral Accounts is cash. The medium of payment for
withdrawals from Gain Share Accounts is Common Stock. The form of payment for
all withdrawals will be a single-sum payment.

                                       15

<PAGE>

                                   ARTICLE IX

                                   BENEFICIARY

     9.01   Beneficiary Designation. A Participant shall designate a Beneficiary
to receive benefits under the Plan on the Election Form provided by the
Committee. If more than one Beneficiary is named, the share and/or precedence of
each Beneficiary shall be indicated. A Participant shall have the right to
change the Beneficiary by submitting to the Committee a new Election Form.

     9.02   Proper Beneficiary. If the Committee has any doubt as to the proper
Beneficiary to receive payments hereunder, the Committee shall have the right to
withhold such payments until the matter is finally adjudicated. However, any
payment made by the Committee, in good faith and in accordance with this Plan,
shall fully discharge the Company from all further obligations with respect to
that payment.

     9.03   Minor or Incompetent Beneficiary. In making any payments to or for
the benefit of any minor or an incompetent Beneficiary, the Committee, in its
sole and absolute discretion, may make a distribution to a legal or natural
guardian or other relative of a minor or court appointed committee of such
incompetent. Alternatively, it may make a payment to any adult with whom the
minor or incompetent temporarily or permanently resides. The receipt by a
guardian, committee, relative or other person shall be a complete discharge to
the Company. Neither the Company nor the Committee shall have any responsibility
to see to the proper application of any payments so made.

     9.04   No Beneficiary Designation. If a Participant fails to designate a
Beneficiary as provided in Section 9.01 above, or if all designated
Beneficiaries predecease the Participant or die prior to complete distribution
of the Participant's benefits, then the Participant's designated Beneficiary
shall be deemed to be his or her surviving spouse. If the Participant has no
surviving spouse, the benefits remaining under the Plan to be paid to a
Beneficiary shall be payable to the executor or personal representative of the
Participant's estate.

                                       16

<PAGE>

                                    ARTICLE X

                           ADMINISTRATION OF THE PLAN

     10.01  Majority Vote. All resolutions or other actions taken by the
Committee shall be by vote of a majority of those present at a meeting at which
a majority of the members are present, or in writing by all the members at the
time in office if they act without a meeting. Such resolutions or actions shall
be confirmed in writing by a Board resolution.

     10.02  Finality of Determination. Subject to the Plan, the Committee shall,
from time to time, establish rules, forms and procedures for the administration
of the Plan. Except as herein otherwise expressly provided, the Committee shall
have the exclusive right to interpret the Plan and to decide any and all matters
arising thereunder or in connection with the administration of the Plan, and it
shall endeavor to act, whether by general rules or by particular decisions, so
as not to discriminate in favor of or against any person. The interpretations,
decisions, actions and records of the Committee shall be conclusive and binding
upon the Company and all persons having or claiming to have any right or
interest in or under the Plan, and cannot be overruled by a court of law unless
arbitrary or capricious.

     10.03  Certificates and Reports. The members of the Committee and the
officers and directors of the Company shall be entitled to rely on all
certificates and reports made by any duly appointed accountants, and on all
opinions given by any duly appointed legal counsel, which legal counsel may be
counsel for the Company.

     10.04  Indemnification and Exculpation. The Company shall indemnify and
hold harmless each current and former member of the Committee and each current
and former member of the Board against any and all expenses and liabilities (to
the extent not indemnified under any liability insurance contract or other
indemnification agreement) which the person incurs on account of any act or
failure to act in connection with the good faith administration of the Plan.
Expenses against which a member of the Committee shall be indemnified hereunder
shall include, without limitation, the amount of any settlement or judgment,
costs, counsel fees, and related charges reasonably incurred in connection with
a claim asserted, or a proceeding brought or settlement thereof. The foregoing
right of indemnification shall be in addition to any other rights to which any
such member of the Committee may be entitled as a matter of law, but shall be
conditioned upon the person's notifying the Company of the claim of liability
within 60 days of the notice of that claim and offering the Company the right to
participate in and control the settlement and defense of the claim. The
foregoing provision will not be applicable to any person if the loss, cost,
liability or expense is due to such person's gross negligence or willful
misconduct.

     10.05  Expenses. The expenses of administering the Plan shall be borne by
the Company.

                                       17

<PAGE>

                                   ARTICLE XI

                                CLAIMS PROCEDURE

     11.01  Written Claim. Benefits shall be paid in accordance with the
provisions of this Plan. The Participant, or a designated Beneficiary or any
other person claiming through the Participant shall make a written request for
benefits under this Plan. This written claim shall be mailed or delivered to the
Committee. Such claim shall be reviewed by the Committee or a delegate.

     11.02  Denied Claim. If the claim is denied, in full or in part, the
Committee shall provide a written notice within ninety (90) days setting forth
the specific reasons for denial, and any additional material or information
necessary to perfect the claim, and an explanation of why such material or
information is necessary, and appropriate information and explanation of the
steps to be taken if a review of the denial is desired.

     11.03  Review Procedure. If the claim is denied and a review is desired,
the Participant (or Beneficiary) shall notify the Committee in writing within
sixty (60) days after receipt of the written notice of denial. In requesting a
review, the Participant or Beneficiary may request a review of pertinent
documents with regard to the benefits created under this agreement, may submit
any written issues and comments, may request an extension of time for such
written submission of issues and comments, and may request that a hearing be
held, but the decision to hold a hearing shall be within the sole discretion of
the Committee.

     11.04  Committee Review. The decision on the review of the denied claim
shall be rendered by the Committee within sixty (60) days after the receipt of
the request for review (if no hearing is held) or within sixty (60) days after
the hearing if one is held. The decision shall be written and shall state the
specific reasons for the decision including reference to specific provisions of
this Plan on which the decision is based.

                                       18

<PAGE>

                                   ARTICLE XII

                         NATURE OF COMPANY'S OBLIGATION

     12.01  Company's Obligation. The Company's obligations under this Plan
shall be an unfunded and unsecured promise to pay. The Company shall not be
obligated under any circumstances to fund its financial obligations under this
Plan.

     12.02  Creditor Status. Any assets which the Company may acquire or set
aside to help cover its financial liabilities hereunder are and must remain
general assets of the Company subject to the claims of its general unsecured
creditors. Neither the Company nor this Plan gives a Participant or Beneficiary
any beneficial ownership interest in any asset of the Company. In the event that
the Company elects to invest funds to pay Deferral Account Balances or Gain
Share Account Balances under the terms of this Plan, title to and beneficial
ownership of such assets shall at all times remain in the Company. All Plan
Participants and Beneficiaries shall be unsecured general creditors of the
Company.

                                       19

<PAGE>

                                  ARTICLE XIII

                        AMENDMENT AND TERMINATION OF PLAN

     13.01  Amendment. The Board reserves the right to amend this Plan from time
to time in whole or in part; provided, however, that no such amendment may
reduce, or relieve the Company of, any obligation with respect to the balance of
any Deferral Account(s) and Gain Share Account(s) maintained under this Plan as
accrued at the time of such amendment, nor shall any amendment otherwise have a
retroactive effect, without the written consent of the affected Participant or
Beneficiary as the case may be.

     13.02  Change in Control. Upon the occurrence of a Change in Control, the
Board may terminate the Plan and distribute Deferral Account Balances and Gain
Share Account Balances in a lump sum or in semi-annual installments over a
period of five (5) years, as specified on the Participant's Election Form and/or
Stock Option Gain Deferral Agreement, in accordance with this Plan.

     13.03  Termination. The Company, by action of the Board, reserves the right
to prospectively terminate this Plan for any reason, provided the Company pays
to each Participant and Beneficiary, the accrued balance of the Participant's
Deferral Account and Gain Share Account (determined as of the date of
termination) as of the date of termination. Such payment will be paid as soon as
administratively possible, but not later than 30 days following the date of
termination.

                                       20

<PAGE>

                                   ARTICLE XIV

                                  MISCELLANEOUS

     14.01  Written Notice. Any notice which shall be or may be given under the
Plan shall be in writing and shall be mailed by United States mail, postage
prepaid. If notice is to be given to the Company, such notice shall be addressed
to the Committee at the Company. If notice is to be given to the Participant,
such notice shall be sent to the Participant's last known address.

     14.02  Change of Address. Any party may, from time to time, change the
address to which notices shall be mailed by giving written notice of such new
address.

     14.03  Merger, Consolidation or Acquisition. The Plan shall be binding upon
the Company, its assigns, and any successor to the Company which shall succeed
to substantially all of its assets and business through merger, acquisition or
consolidation, and upon a Participant, a Beneficiary, assigns, heirs, executors
and administrators.

     14.04  Employment. Neither the creation of this Plan or anything contained
herein shall be construed as giving any Participant hereunder any right to
continuous service with the Company as a Director.

     14.05  Non-transferability. Except insofar as prohibited by applicable law,
no sale, transfer, alienation, assignment, pledge, collateralization or
attachment of any benefits under this Plan shall be valid or recognized by the
Company. Neither the Participant, spouse, or designated Beneficiary shall have
any power to hypothecate, mortgage, commute, modify, or otherwise encumber in
advance of any of the benefits payable hereunder, nor shall any of said benefits
be subject to seizure for the payment of any debts, judgments, alimony
maintenance, owed by the Participant or Beneficiary, or be transferable by
operation of law in the event of bankruptcy, insolvency, or otherwise.

     14.06  Legal Fees. All reasonable legal fees incurred by any Participant
(or former Participant) to successfully enforce valid rights under this Plan
shall be paid by the Company in addition to sums due under this Plan.

     14.07  Tax Withholding. The Company may withhold from a payment any
federal, state, or local taxes required by law to be withheld with respect to
such payment and such sum as the Company may reasonably estimate as necessary to
cover any taxes for which the Company may be liable and which may be assessed
with regard to such payment.

     14.08  Acceleration of Payment. The Company reserves the right to
accelerate the payment of any benefits payable under this Plan at any time
without the consent of the Participant, the Participant's estate, a Beneficiary
or any other person claiming through the Participant.

                                       21

<PAGE>

     14.09  Applicable Law. This Plan shall be governed by the laws of the State
of North Carolina, without regard to the conflicts-of-law rules of such State,
to the extent not preempted by the laws of the United States of America.

     14.10  Invalidity of Certain Provisions. If any provision of this Plan is
held invalid or unenforceable, such invalidity or unenforceability will not
affect any other provisions hereof and this Plan will be construed and enforced
as if such provisions, to the extent invalid or unenforceable, had not been
included.

IN WITNESS WHEREOF, the Company has caused this Plan to be executed by its duly
authorized officer on this 17/th/ day of June, 2002, effective as of the 15/th/
day of June, 2002.

PHARMACEUTICAL PRODUCT DEVELOPMENT, INC.

By  /s/ Fredric N. Eshelman
   -----------------------------
    Chief Executive Officer
              (Title)

ATTEST:

By  /s/ B. Judd Hartman
   -----------------------------
    Secretary

[SEAL]

                                       22

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00042-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00042-of-00352.parquet"}]]